Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	glucuronosyltransferase activity	UGT2A2 UGT2A1 UGT2B4 UGT2B7 UGT2B10 UGT2B15 UGT2B17	6.02e-09	35	148	7	GO:0015020
GeneOntologyMolecularFunction	methyl-CpG binding	MBD3L5 MBD3L2 MBD3L3 MBD3L4 MBD3L2B	3.04e-06	31	148	5	GO:0008327
GeneOntologyMolecularFunction	protein serine kinase activity	CDK9 TNIK CAMK1D ERN1 TRPM7 MKNK2 PIK3R4 STK4 TTBK2 LATS1 MAP2K1 ULK2 DYRK2	3.20e-06	363	148	13	GO:0106310
GeneOntologyMolecularFunction	ATP-dependent protein folding chaperone	CCT6A CCT6B HSPA6 HSPA7 HSPA8	1.12e-05	40	148	5	GO:0140662
GeneOntologyMolecularFunction	chromatin insulator sequence binding	ZFX ZFY ZNF276	1.37e-05	7	148	3	GO:0043035
GeneOntologyMolecularFunction	phosphotransferase activity, alcohol group as acceptor	EPHB2 CDK9 TNIK CAMK1D ERN1 TRPM7 MKNK2 DGKB DGKG PIK3R4 STK4 TTBK2 LATS1 FGR MAP2K1 ULK2 DYRK2	2.08e-05	709	148	17	GO:0016773
GeneOntologyMolecularFunction	protein serine/threonine kinase activity	CDK9 TNIK CAMK1D ERN1 TRPM7 MKNK2 PIK3R4 STK4 TTBK2 LATS1 MAP2K1 ULK2 DYRK2	2.87e-05	446	148	13	GO:0004674
GeneOntologyMolecularFunction	protein kinase activity	EPHB2 CDK9 TNIK CAMK1D ERN1 TRPM7 MKNK2 PIK3R4 STK4 TTBK2 LATS1 FGR MAP2K1 ULK2 DYRK2	4.08e-05	600	148	15	GO:0004672
GeneOntologyMolecularFunction	retinoic acid binding	UGT2B4 UGT2B7 UGT2B15 UGT2B17	5.17e-05	28	148	4	GO:0001972
GeneOntologyMolecularFunction	kinase activity	EPHB2 CDK9 TNIK CAMK1D ERN1 TRPM7 MKNK2 DGKB DGKG PIK3R4 STK4 TTBK2 LATS1 FGR MAP2K1 ULK2 DYRK2	5.30e-05	764	148	17	GO:0016301
GeneOntologyMolecularFunction	transferase activity, transferring phosphorus-containing groups	EPHB2 CDK9 TNIK CTU2 CAMK1D ERN1 TRPM7 POLR2B MKNK2 DGKB DGKG PIK3R4 STK4 TTBK2 LATS1 FGR MAP2K1 ULK2 DYRK2	6.66e-05	938	148	19	GO:0016772
GeneOntologyMolecularFunction	UDP-glycosyltransferase activity	UGT2A2 UGT2A1 UGT2B4 UGT2B7 UGT2B10 UGT2B15 UGT2B17	1.47e-04	153	148	7	GO:0008194
GeneOntologyMolecularFunction	RNA polymerase II transcription regulatory region sequence-specific DNA binding	CDK9 ZBTB20 HDAC6 DPRX ZNF780B GLIS3 ZNF496 ZNF416 ZNF441 PRDM2 ZFX ZFY ZBTB49 BCL11B ZNF605 ZNF684 ZNF780A ZNF341 SP5 ZNF606 ZBTB11 PRDM15 THRAP3 GLIS1	1.82e-04	1459	148	24	GO:0000977
GeneOntologyMolecularFunction	protein folding chaperone	CCT6A CCT6B HSPA6 HSPA7 HSPA8	2.09e-04	73	148	5	GO:0044183
GeneOntologyMolecularFunction	RNA polymerase II cis-regulatory region sequence-specific DNA binding	CDK9 ZBTB20 HDAC6 DPRX ZNF780B GLIS3 ZNF496 ZNF416 ZFX ZFY ZBTB49 BCL11B ZNF605 ZNF780A ZNF341 SP5 ZNF606 ZBTB11 PRDM15 THRAP3 GLIS1	3.42e-04	1244	148	21	GO:0000978
GeneOntologyMolecularFunction	retinoid binding	UGT2B4 UGT2B7 UGT2B15 UGT2B17	4.38e-04	48	148	4	GO:0005501
GeneOntologyMolecularFunction	cis-regulatory region sequence-specific DNA binding	CDK9 ZBTB20 HDAC6 DPRX ZNF780B GLIS3 ZNF496 ZNF416 ZFX ZFY ZBTB49 BCL11B ZNF605 ZNF780A ZNF341 SP5 ZNF606 ZBTB11 PRDM15 THRAP3 GLIS1	4.54e-04	1271	148	21	GO:0000987
GeneOntologyMolecularFunction	isoprenoid binding	UGT2B4 UGT2B7 UGT2B15 UGT2B17	4.74e-04	49	148	4	GO:0019840
GeneOntologyMolecularFunction	hexosyltransferase activity	UGT2A2 UGT2A1 UGT2B4 UGT2B7 UGT2B10 UGT2B15 UGT2B17	1.01e-03	211	148	7	GO:0016758
GeneOntologyMolecularFunction	lyase activity	GAD1 DGLUCY GUCY1B2 HTD2 CTH MOCS1 MOCOS	1.04e-03	212	148	7	GO:0016829
GeneOntologyMolecularFunction	DNA-binding transcription activator activity	ZNF780B GLIS3 PRDM2 ZFX ZFY BCL11B ZNF605 ZNF780A ZNF341 ZNF606 PRDM15 GLIS1	1.06e-03	566	148	12	GO:0001216
GeneOntologyMolecularFunction	translation termination factor activity	GSPT1 MTRF1L	1.12e-03	7	148	2	GO:0008079
GeneOntologyMolecularFunction	translation release factor activity	GSPT1 MTRF1L	1.12e-03	7	148	2	GO:0003747
GeneOntologyMolecularFunction	monocarboxylic acid binding	ACACB UGT2B4 UGT2B7 UGT2B15 UGT2B17	1.21e-03	107	148	5	GO:0033293
GeneOntologyMolecularFunction	heat shock protein binding	HDAC6 ERN1 DLST HSPA6 HSPA7 HSPA8	1.37e-03	163	148	6	GO:0031072
GeneOntologyMolecularFunction	DNA-binding transcription factor activity, RNA polymerase II-specific	ZBTB20 DPRX ZNF780B GLIS3 ZNF496 ZNF416 ZNF441 PRDM2 ZFX ZFY ZBTB49 BCL11B ZNF605 ZNF684 ZNF780A ZNF341 SP5 ZNF606 ZBTB11 PRDM15 GLIS1	1.72e-03	1412	148	21	GO:0000981
GeneOntologyMolecularFunction	unfolded protein binding	ERN1 CCT6A CCT6B HSPA6 HSPA8	2.49e-03	126	148	5	GO:0051082
GeneOntologyMolecularFunction	ATP-dependent diacylglycerol kinase activity	DGKB DGKG	2.87e-03	11	148	2	GO:0004143
GeneOntologyMolecularFunction	DNA-binding transcription activator activity, RNA polymerase II-specific	ZNF780B GLIS3 PRDM2 ZFX ZFY BCL11B ZNF605 ZNF780A ZNF606 PRDM15 GLIS1	3.08e-03	560	148	11	GO:0001228
GeneOntologyMolecularFunction	sulfurtransferase activity	CTU2 MOCOS	3.43e-03	12	148	2	GO:0016783
GeneOntologyBiologicalProcess	cellular glucuronidation	ABHD10 UGT2A2 UGT2A1 UGT2B4 UGT2B7 UGT2B10 UGT2B15 UGT2B17	1.03e-12	21	147	8	GO:0052695
GeneOntologyBiologicalProcess	glucuronate metabolic process	ABHD10 UGT2A2 UGT2A1 UGT2B4 UGT2B7 UGT2B10 UGT2B15 UGT2B17	7.70e-12	26	147	8	GO:0019585
GeneOntologyBiologicalProcess	uronic acid metabolic process	ABHD10 UGT2A2 UGT2A1 UGT2B4 UGT2B7 UGT2B10 UGT2B15 UGT2B17	7.70e-12	26	147	8	GO:0006063
GeneOntologyBiologicalProcess	biphenyl catabolic process	UGT2B4 UGT2B7 UGT2B10 UGT2B15 UGT2B17	9.45e-10	8	147	5	GO:0070980
GeneOntologyBiologicalProcess	biphenyl metabolic process	UGT2B4 UGT2B7 UGT2B10 UGT2B15 UGT2B17	4.21e-09	10	147	5	GO:0018879
GeneOntologyBiologicalProcess	xenobiotic glucuronidation	UGT2B4 UGT2B7 UGT2B10 UGT2B15 UGT2B17	1.31e-08	12	147	5	GO:0052697
GeneOntologyBiologicalProcess	benzene-containing compound metabolic process	UGT2B4 UGT2B7 UGT2B10 UGT2B15 UGT2B17	6.23e-06	37	147	5	GO:0042537
GeneOntologyBiologicalProcess	xenobiotic catabolic process	UGT2B4 UGT2B7 UGT2B10 UGT2B15 UGT2B17	6.23e-06	37	147	5	GO:0042178
GeneOntologyBiologicalProcess	androgen metabolic process	UGT2B4 UGT2B7 UGT2B10 UGT2B15 UGT2B17	7.13e-06	38	147	5	GO:0008209
GeneOntologyBiologicalProcess	DNA methylation-dependent constitutive heterochromatin formation	MBD3L5 MBD3L2 MBD3L3 MBD3L4 MBD3L2B	1.49e-05	44	147	5	GO:0006346
GeneOntologyBiologicalProcess	negative regulation of gene expression, epigenetic	MBD3L5 HDAC6 MBD3L2 MBD3L3 MBD3L4 TRIP12 ZFY MBD3L2B USP7	1.55e-05	203	147	9	GO:0045814
GeneOntologyBiologicalProcess	estrogen metabolic process	UGT2B4 UGT2B7 UGT2B10 UGT2B15 UGT2B17	3.41e-05	52	147	5	GO:0008210
GeneOntologyBiologicalProcess	facultative heterochromatin formation	MBD3L5 MBD3L2 MBD3L3 MBD3L4 MBD3L2B	4.48e-05	55	147	5	GO:0140718
GeneOntologyBiologicalProcess	epicardium-derived cardiac vascular smooth muscle cell differentiation	PROK2 CTNNB1	5.05e-05	2	147	2	GO:0060983
GeneOntologyBiologicalProcess	heterochromatin formation	MBD3L5 MBD3L2 MBD3L3 MBD3L4 TRIP12 ZFY MBD3L2B	1.71e-04	163	147	7	GO:0031507
GeneOntologyCellularComponent	nuclear outer membrane	UGT2B4 UGT2B7 UGT2B10 UGT2B15 UGT2B17	8.96e-06	40	148	5	GO:0005640
MousePheno	abnormal vertical activity	CDK9 ABCA2 UGT2A2 DGKB CERS6 SELENON GSPT1 CACNG2 BCL11B CLCN1 ASPA UGT2A1 SP5	2.44e-05	439	105	13	MP:0020167
Domain	Znf_C2H2/integrase_DNA-bd	ZBTB20 ZNF155 ZNF780B GLIS3 ZNF576 ZNF496 ZNF416 ZNF441 PRDM2 ZFX ZFY ZBTB49 ZBTB44 ZNF469 ZNF276 BCL11B ZNF605 ZNF684 ZNF780A ZNF341 SP5 ZNF606 ZBTB11 PRDM15 ZNF654 GLIS1 ZNF541 ZNF222	4.10e-13	694	143	28	IPR013087
Domain	ZINC_FINGER_C2H2_1	ZBTB20 ZNF155 ZNF780B GLIS3 ZNF576 ZNF496 ZNF416 ZNF441 PRDM2 ZFX ZFY ZBTB49 ZBTB44 ZNF469 ZNF276 BCL11B ZNF605 ZNF684 ZNF780A ZNF341 SP5 ZFR ZNF606 ZBTB11 PRDM15 ZNF654 GLIS1 ZNF541 ZNF222	1.02e-12	777	143	29	PS00028
Domain	-	ZBTB20 ZNF155 ZNF780B GLIS3 ZNF576 ZNF496 ZNF416 ZNF441 PRDM2 ZFX ZFY ZBTB49 ZBTB44 ZNF276 BCL11B ZNF605 ZNF684 ZNF780A ZNF341 SP5 ZNF606 ZBTB11 PRDM15 ZNF654 GLIS1 ZNF541 ZNF222	1.61e-12	679	143	27	3.30.160.60
Domain	Znf_C2H2-like	ZBTB20 ZNF155 ZNF780B GLIS3 ZNF576 ZNF496 ZNF416 ZNF441 PRDM2 ZFX ZFY ZBTB49 ZBTB44 ZNF469 ZNF276 BCL11B ZNF605 ZNF684 ZNF780A ZNF341 SP5 ZFR ZNF606 ZBTB11 PRDM15 ZNF654 GLIS1 ZNF541 ZNF222	1.86e-12	796	143	29	IPR015880
Domain	Znf_C2H2	ZBTB20 ZNF155 ZNF780B GLIS3 ZNF576 ZNF496 ZNF416 ZNF441 PRDM2 ZFX ZFY ZBTB49 ZBTB44 ZNF469 ZNF276 BCL11B ZNF605 ZNF684 ZNF780A ZNF341 SP5 ZFR ZNF606 ZBTB11 PRDM15 ZNF654 GLIS1 ZNF541 ZNF222	2.45e-12	805	143	29	IPR007087
Domain	zf-C2H2	ZBTB20 ZNF155 ZNF780B GLIS3 ZNF576 ZNF496 ZNF416 ZNF441 PRDM2 ZFX ZFY ZBTB49 ZBTB44 ZNF469 ZNF276 BCL11B ZNF605 ZNF684 ZNF780A ZNF341 SP5 ZNF606 ZBTB11 PRDM15 GLIS1 ZNF541 ZNF222	2.59e-12	693	143	27	PF00096
Domain	ZnF_C2H2	ZBTB20 ZNF155 ZNF780B GLIS3 ZNF576 ZNF496 ZNF416 ZNF441 PRDM2 ZFX ZFY ZBTB49 ZBTB44 ZNF469 ZNF276 BCL11B ZNF605 ZNF684 ZNF780A ZNF341 SP5 ZFR ZNF606 ZBTB11 PRDM15 ZNF654 GLIS1 ZNF541 ZNF222	2.68e-12	808	143	29	SM00355
Domain	ZINC_FINGER_C2H2_2	ZBTB20 ZNF155 ZNF780B GLIS3 ZNF576 ZNF496 ZNF416 ZNF441 PRDM2 ZFX ZFY ZBTB49 ZBTB44 ZNF469 ZNF276 BCL11B ZNF605 ZNF684 ZNF780A ZNF341 SP5 ZNF606 ZBTB11 PRDM15 ZNF654 GLIS1 ZNF541 ZNF222	5.81e-12	775	143	28	PS50157
Domain	UDPGT	UGT2A1 UGT2B4 UGT2B7 UGT2B10 UGT2B15 UGT2B17	8.95e-09	21	143	6	PF00201
Domain	UDPGT	UGT2A1 UGT2B4 UGT2B7 UGT2B10 UGT2B15 UGT2B17	8.95e-09	21	143	6	PS00375
Domain	UDP_glucos_trans	UGT2A1 UGT2B4 UGT2B7 UGT2B10 UGT2B15 UGT2B17	8.95e-09	21	143	6	IPR002213
Domain	MeCpG-bd_2/3_C_dom	MBD3L5 MBD3L2 MBD3L3 MBD3L4	1.13e-07	7	143	4	IPR025884
Domain	MBD2/MBD3_p55-bd	MBD3L5 MBD3L2 MBD3L3 MBD3L4	1.13e-07	7	143	4	IPR032343
Domain	MBDa	MBD3L5 MBD3L2 MBD3L3 MBD3L4	1.13e-07	7	143	4	PF16564
Domain	MBD_C	MBD3L5 MBD3L2 MBD3L3 MBD3L4	1.13e-07	7	143	4	PF14048
Domain	zf-C2H2_6	ZNF155 ZNF780B ZNF576 ZNF416 PRDM2 ZBTB49 ZBTB44 ZNF605 ZNF684 ZNF780A ZNF606 ZBTB11 ZNF541	9.05e-07	314	143	13	PF13912
Domain	Kinase-like_dom	EPHB2 CDK9 TNIK CAMK1D ERN1 TRPM7 MKNK2 PRDM2 PIK3R4 STK4 TTBK2 LATS1 FGR MAP2K1 ULK2 DYRK2	4.15e-06	542	143	16	IPR011009
Domain	PROTEIN_KINASE_ATP	EPHB2 CDK9 TNIK CAMK1D ERN1 MKNK2 PIK3R4 STK4 TTBK2 LATS1 FGR MAP2K1 ULK2 DYRK2	1.19e-05	459	143	14	PS00107
Domain	S_TKc	CDK9 TNIK CAMK1D ERN1 MKNK2 PIK3R4 STK4 TTBK2 LATS1 MAP2K1 ULK2 DYRK2	2.11e-05	359	143	12	SM00220
Domain	PROTEIN_KINASE_ST	CDK9 TNIK CAMK1D ERN1 MKNK2 PIK3R4 STK4 TTBK2 LATS1 MAP2K1 ULK2 DYRK2	2.29e-05	362	143	12	PS00108
Domain	Prot_kinase_dom	EPHB2 CDK9 TNIK CAMK1D ERN1 MKNK2 PIK3R4 STK4 TTBK2 LATS1 FGR MAP2K1 ULK2 DYRK2	2.40e-05	489	143	14	IPR000719
Domain	PROTEIN_KINASE_DOM	EPHB2 CDK9 TNIK CAMK1D ERN1 MKNK2 PIK3R4 STK4 TTBK2 LATS1 FGR MAP2K1 ULK2 DYRK2	2.63e-05	493	143	14	PS50011
Domain	Pkinase	CDK9 TNIK CAMK1D ERN1 MKNK2 PIK3R4 STK4 TTBK2 LATS1 MAP2K1 ULK2 DYRK2	3.77e-05	381	143	12	PF00069
Domain	Chap_CCT_zeta	CCT6A CCT6B	5.82e-05	2	143	2	IPR012722
Domain	Ribosomal_L26	RPL26 RPL26L1	5.82e-05	2	143	2	PF16906
Domain	Ribosomal_L26/L24P_euk/arc	RPL26 RPL26L1	5.82e-05	2	143	2	IPR005756
Domain	Ser/Thr_kinase_AS	CDK9 TNIK CAMK1D ERN1 MKNK2 PIK3R4 STK4 LATS1 MAP2K1 ULK2 DYRK2	9.73e-05	357	143	11	IPR008271
Domain	Protein_kinase_ATP_BS	EPHB2 CDK9 TNIK CAMK1D MKNK2 STK4 TTBK2 FGR MAP2K1 ULK2 DYRK2	1.64e-04	379	143	11	IPR017441
Domain	Ribosomal_L24/26_CS	RPL26 RPL26L1	1.74e-04	3	143	2	IPR005825
Domain	Transcrp_activ_Zfx/Zfy-dom	ZFX ZFY	1.74e-04	3	143	2	IPR006794
Domain	-	DGKB DGKG	1.74e-04	3	143	2	1.10.238.110
Domain	RIBOSOMAL_L24	RPL26 RPL26L1	1.74e-04	3	143	2	PS01108
Domain	Zfx_Zfy_act	ZFX ZFY	1.74e-04	3	143	2	PF04704
Domain	DAG_kinase_N	DGKB DGKG	1.74e-04	3	143	2	PF14513
Domain	DAG_kinase_typeI_N	DGKB DGKG	1.74e-04	3	143	2	IPR029477
Domain	HSP70	HSPA6 HSPA7 HSPA8	2.29e-04	16	143	3	PF00012
Domain	HSP70_2	HSPA6 HSPA7 HSPA8	2.76e-04	17	143	3	PS00329
Domain	HSP70_1	HSPA6 HSPA7 HSPA8	2.76e-04	17	143	3	PS00297
Domain	HSP70_3	HSPA6 HSPA7 HSPA8	2.76e-04	17	143	3	PS01036
Domain	Hsp_70_fam	HSPA6 HSPA7 HSPA8	3.30e-04	18	143	3	IPR013126
Domain	KRAB	ZNF155 ZNF780B ZNF496 ZNF416 ZNF441 ZNF605 ZNF684 ZNF780A ZNF606 ZNF222	4.42e-04	358	143	10	PS50805
Domain	KRAB	ZNF155 ZNF780B ZNF496 ZNF416 ZNF441 ZNF605 ZNF684 ZNF780A ZNF606 ZNF222	4.42e-04	358	143	10	PF01352
Domain	KRAB	ZNF155 ZNF780B ZNF496 ZNF416 ZNF441 ZNF605 ZNF684 ZNF780A ZNF606 ZNF222	5.60e-04	369	143	10	SM00349
Domain	KRAB	ZNF155 ZNF780B ZNF496 ZNF416 ZNF441 ZNF605 ZNF684 ZNF780A ZNF606 ZNF222	5.71e-04	370	143	10	IPR001909
Domain	VWA_2	PSMD4 INTS14	5.73e-04	5	143	2	PF13519
Domain	KOW	RPL26 RPL26L1	1.19e-03	7	143	2	SM00739
Domain	Chaprnin_Cpn60	CCT6A CCT6B	2.02e-03	9	143	2	IPR001844
Domain	Chaperonin_TCP-1_CS	CCT6A CCT6B	2.02e-03	9	143	2	IPR002194
Domain	Biotin_lipoyl	ACACB DLST	2.02e-03	9	143	2	PF00364
Domain	-	GAD1 CTH MOCOS	2.40e-03	35	143	3	3.90.1150.10
Domain	DAGK_acc	DGKB DGKG	2.52e-03	10	143	2	PF00609
Domain	Diacylglycerol_kin_accessory	DGKB DGKG	2.52e-03	10	143	2	IPR000756
Domain	TCP1_1	CCT6A CCT6B	2.52e-03	10	143	2	PS00750
Domain	TCP1_2	CCT6A CCT6B	2.52e-03	10	143	2	PS00751
Domain	TCP1_3	CCT6A CCT6B	2.52e-03	10	143	2	PS00995
Domain	BIOTINYL_LIPOYL	ACACB DLST	2.52e-03	10	143	2	PS50968
Domain	Biotin_lipoyl	ACACB DLST	2.52e-03	10	143	2	IPR000089
Domain	Chaperone_TCP-1	CCT6A CCT6B	2.52e-03	10	143	2	IPR017998
Domain	DAGKa	DGKB DGKG	2.52e-03	10	143	2	SM00045
Domain	PyrdxlP-dep_Trfase_major_sub2	GAD1 CTH MOCOS	2.61e-03	36	143	3	IPR015422
Domain	KOW	RPL26 RPL26L1	3.06e-03	11	143	2	IPR005824
Domain	KOW	RPL26 RPL26L1	3.06e-03	11	143	2	PF00467
Domain	-	CCT6A CCT6B	3.06e-03	11	143	2	3.30.260.10
Domain	TCP-1-like_intermed	CCT6A CCT6B	3.06e-03	11	143	2	IPR027410
Domain	-	GAD1 CTH MOCOS	3.28e-03	39	143	3	3.40.640.10
Domain	BTB	ZBTB20 ZBTB49 ZBTB44 KBTBD4 ZBTB11	3.37e-03	131	143	5	PF00651
Domain	Single_hybrid_motif	ACACB DLST	3.65e-03	12	143	2	IPR011053
Domain	-	HSPA6 HSPA8	3.65e-03	12	143	2	2.60.34.10
Domain	HSP70_peptide-bd	HSPA6 HSPA8	3.65e-03	12	143	2	IPR029047
Domain	PyrdxlP-dep_Trfase	GAD1 CTH MOCOS	3.79e-03	41	143	3	IPR015424
Domain	PyrdxlP-dep_Trfase_major_sub1	GAD1 CTH MOCOS	3.79e-03	41	143	3	IPR015421
Domain	-	HSPA6 HSPA8	4.30e-03	13	143	2	1.20.1270.10
Domain	Heat_shock_70_CS	HSPA6 HSPA8	4.30e-03	13	143	2	IPR018181
Domain	HSP70_C	HSPA6 HSPA8	4.30e-03	13	143	2	IPR029048
Domain	GROEL-like_equatorial	CCT6A CCT6B	4.99e-03	14	143	2	IPR027413
Domain	-	CCT6A CCT6B	4.99e-03	14	143	2	1.10.560.10
Domain	DAGKc	DGKB DGKG	4.99e-03	14	143	2	SM00046
Domain	Diacylglycerol_kinase_cat_dom	DGKB DGKG	5.73e-03	15	143	2	IPR001206
Domain	DAGK	DGKB DGKG	5.73e-03	15	143	2	PS50146
Domain	GroEL-like_apical_dom	CCT6A CCT6B	5.73e-03	15	143	2	IPR027409
Domain	Cpn60/TCP-1	CCT6A CCT6B	5.73e-03	15	143	2	IPR002423
Domain	Cpn60_TCP1	CCT6A CCT6B	5.73e-03	15	143	2	PF00118
Domain	-	CCT6A CCT6B	5.73e-03	15	143	2	3.50.7.10
Domain	DAGK_cat	DGKB DGKG	5.73e-03	15	143	2	PF00781
Domain	Disintegrin_CS	ADAM21 ADAM22	6.51e-03	16	143	2	IPR018358
Domain	NAD/diacylglycerol_kinase	DGKB DGKG	7.34e-03	17	143	2	IPR016064
Domain	Translation_prot_SH3-like	RPL26 RPL26L1	7.34e-03	17	143	2	IPR008991
Pathway	REACTOME_GLUCURONIDATION	ABHD10 UGT2A2 UGT2A1 UGT2B4 UGT2B7 UGT2B10 UGT2B15 UGT2B17	6.53e-12	24	109	8	MM14599
Pathway	REACTOME_GLUCURONIDATION	ABHD10 UGT2A2 UGT2A1 UGT2B4 UGT2B7 UGT2B10 UGT2B15 UGT2B17	9.55e-12	25	109	8	M17787
Pathway	WP_GLUCURONIDATION	UGT2A2 UGT2A1 UGT2B4 UGT2B7 UGT2B10 UGT2B15 UGT2B17	5.83e-10	25	109	7	MM15820
Pathway	WP_GLUCURONIDATION	UGT2A2 UGT2A1 UGT2B4 UGT2B7 UGT2B10 UGT2B15 UGT2B17	7.93e-10	26	109	7	M39404
Pathway	KEGG_PORPHYRIN_AND_CHLOROPHYLL_METABOLISM	BLVRB UGT2A1 UGT2B4 UGT2B7 UGT2B10 UGT2B15 UGT2B17	2.46e-08	41	109	7	M7399
Pathway	KEGG_ASCORBATE_AND_ALDARATE_METABOLISM	UGT2A1 UGT2B4 UGT2B7 UGT2B10 UGT2B15 UGT2B17	2.92e-08	25	109	6	M605
Pathway	REACTOME_ASPIRIN_ADME	UGT2A2 UGT2A1 UGT2B4 UGT2B7 UGT2B10 UGT2B15 UGT2B17	4.12e-08	44	109	7	M45014
Pathway	REACTOME_ASPIRIN_ADME	UGT2A2 UGT2A1 UGT2B4 UGT2B7 UGT2B10 UGT2B15 UGT2B17	4.85e-08	45	109	7	MM15694
Pathway	KEGG_PENTOSE_AND_GLUCURONATE_INTERCONVERSIONS	UGT2A1 UGT2B4 UGT2B7 UGT2B10 UGT2B15 UGT2B17	6.10e-08	28	109	6	M19580
Pathway	REACTOME_PREDNISONE_ADME	UGT2B4 UGT2B7 UGT2B10 UGT2B15 UGT2B17	7.59e-07	23	109	5	MM16639
Pathway	REACTOME_PHASE_II_CONJUGATION_OF_COMPOUNDS	ABHD10 UGT2A2 UGT2A1 UGT2B4 UGT2B7 UGT2B10 UGT2B15 UGT2B17	1.70e-06	107	109	8	MM14595
Pathway	REACTOME_PHASE_II_CONJUGATION_OF_COMPOUNDS	ABHD10 UGT2A2 UGT2A1 UGT2B4 UGT2B7 UGT2B10 UGT2B15 UGT2B17	1.96e-06	109	109	8	M18788
Pathway	KEGG_DRUG_METABOLISM_OTHER_ENZYMES	UGT2A1 UGT2B4 UGT2B7 UGT2B10 UGT2B15 UGT2B17	2.53e-06	51	109	6	M17726
Pathway	KEGG_STARCH_AND_SUCROSE_METABOLISM	UGT2A1 UGT2B4 UGT2B7 UGT2B10 UGT2B15 UGT2B17	2.84e-06	52	109	6	M14171
Pathway	KEGG_STEROID_HORMONE_BIOSYNTHESIS	UGT2A1 UGT2B4 UGT2B7 UGT2B10 UGT2B15 UGT2B17	3.96e-06	55	109	6	M14933
Pathway	KEGG_RETINOL_METABOLISM	UGT2A1 UGT2B4 UGT2B7 UGT2B10 UGT2B15 UGT2B17	9.69e-06	64	109	6	M9488
Pathway	REACTOME_PARACETAMOL_ADME	UGT2B4 UGT2B7 UGT2B10 UGT2B15 UGT2B17	1.18e-05	39	109	5	MM15695
Pathway	KEGG_METABOLISM_OF_XENOBIOTICS_BY_CYTOCHROME_P450	UGT2A1 UGT2B4 UGT2B7 UGT2B10 UGT2B15 UGT2B17	1.63e-05	70	109	6	M16794
Pathway	KEGG_DRUG_METABOLISM_CYTOCHROME_P450	UGT2A1 UGT2B4 UGT2B7 UGT2B10 UGT2B15 UGT2B17	1.92e-05	72	109	6	M9257
Pathway	REACTOME_DRUG_ADME	UGT2A2 UGT2A1 UGT2B4 UGT2B7 UGT2B10 UGT2B15 UGT2B17	2.12e-05	109	109	7	M45012
Pathway	REACTOME_DRUG_ADME	UGT2A2 UGT2A1 UGT2B4 UGT2B7 UGT2B10 UGT2B15 UGT2B17	3.74e-05	119	109	7	MM15692
Pathway	REACTOME_BIOLOGICAL_OXIDATIONS	ABHD10 UGT2A2 UGT2A1 UGT2B4 UGT2B7 UGT2B10 UGT2B15 UGT2B17	2.96e-04	219	109	8	MM14838
Pathway	REACTOME_BIOLOGICAL_OXIDATIONS	ABHD10 UGT2A2 UGT2A1 UGT2B4 UGT2B7 UGT2B10 UGT2B15 UGT2B17	3.05e-04	220	109	8	M10320
Pathway	REACTOME_MOLYBDENUM_COFACTOR_BIOSYNTHESIS	MOCS1 MOCOS	5.83e-04	5	109	2	MM15649
Pubmed	MBD3L1 and MBD3L2, two new proteins homologous to the methyl-CpG-binding proteins MBD2 and MBD3: characterization of MBD3L1 as a testis-specific transcriptional repressor.	MBD3L5 MBD3L2 MBD3L3 MBD3L4 MBD3L2B	7.80e-12	6	148	5	12504854
Pubmed	Haploid male germ cell- and oocyte-specific Mbd3l1 and Mbd3l2 genes are dispensable for early development, fertility, and zygotic DNA demethylation in the mouse.	MBD3L5 MBD3L2 MBD3L3 MBD3L4 MBD3L2B	7.80e-12	6	148	5	18942147
Pubmed	Weak activity of UDP-glucuronosyltransferase toward Bisphenol analogs in mouse perinatal development.	UGT2B4 UGT2B7 UGT2B10 UGT2B15 UGT2B17	2.72e-11	7	148	5	26074487
Pubmed	Hetero-oligomer formation of mouse UDP-glucuronosyltransferase (UGT) 2b1 and 1a1 results in the gain of glucuronidation activity towards morphine, an activity which is absent in homo-oligomers of either UGT.	UGT2B4 UGT2B7 UGT2B10 UGT2B15 UGT2B17	7.23e-11	8	148	5	32093886
Pubmed	Polymorphic gene regulation and interindividual variation of UDP-glucuronosyltransferase activity in human small intestine.	UGT2A1 UGT2B4 UGT2B7 UGT2B10 UGT2B15	7.23e-11	8	148	5	10748067
Pubmed	The configuration of the 17-hydroxy group variably influences the glucuronidation of beta-estradiol and epiestradiol by human UDP-glucuronosyltransferases.	UGT2A1 UGT2B4 UGT2B7 UGT2B15 UGT2B17	7.23e-11	8	148	5	18719240
Pubmed	Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function.	HDAC6 POLR2B DHX38 PTPN23 PSMD4 RRM2 PRPF8 TRIP12 NCCRP1 GSPT1 PIK3R4 STK4 CCT6A NSA2 USP7 ANKIB1 CCT6B PUM3 DLST ZFR HSPA6 VARS1 THRAP3 HSPA8 RPL15	6.22e-10	1353	148	25	29467282
Pubmed	MYC multimers shield stalled replication forks from RNA polymerase.	CDK9 RPL26 DHX38 RCN1 PSMD4 PRPF8 TRIP12 CCT6A NSA2 RPL26L1 USP7 NOC4L PUM3 ZFR CTNNB1 ZBTB11 HSPA6 VARS1 THRAP3 HSPA8 RPL15	1.51e-09	989	148	21	36424410
Pubmed	MBD3L2 interacts with MBD3 and components of the NuRD complex and can oppose MBD2-MeCP1-mediated methylation silencing.	MBD3L5 MBD3L2 MBD3L3 MBD3L4 MBD3L2B	3.78e-09	15	148	5	15701600
Pubmed	Associations between polymorphisms in glucuronidation and sulfation enzymes and mammographic breast density in premenopausal women in the United States.	UGT2B4 UGT2B7 UGT2B15 UGT2B17	2.17e-08	8	148	4	20142249
Pubmed	Chr21 protein-protein interactions: enrichment in proteins involved in intellectual disability, autism, and late-onset Alzheimer's disease.	ABCA2 HDAC6 TTC28 TRPM7 DIS3L PSMD4 PRPF8 TRIP12 ADAM22 PIK3R4 ZBTB44 DGLUCY KANSL2 ZNF605 ASPA ARID5B USP7 DLST ZNF606 ZBTB11 VARS1 RPL15	2.91e-08	1285	148	22	35914814
Pubmed	Clopidogrel Carboxylic Acid Glucuronidation is Mediated Mainly by UGT2B7, UGT2B4, and UGT2B17: Implications for Pharmacogenetics and Drug-Drug Interactions .	UGT2B4 UGT2B7 UGT2B17	7.55e-08	3	148	3	29138287
Pubmed	Isolation of a human YAC contig encompassing a cluster of UGT2 genes and its regional localization to chromosome 4q13.	UGT2B4 UGT2B7 UGT2B15	7.55e-08	3	148	3	7835904
Pubmed	Tissue distribution and relative gene expression of UDP-glucuronosyltransferases (2B7, 2B15, 2B17) in the human fetus.	UGT2B7 UGT2B15 UGT2B17	7.55e-08	3	148	3	23223495
Pubmed	Role of UDP-glucuronosyltransferase isoforms in 13-cis retinoic acid metabolism in humans.	UGT2B4 UGT2B7 UGT2B15 UGT2B17	1.52e-07	12	148	4	20308471
Pubmed	In silico APC/C substrate discovery reveals cell cycle-dependent degradation of UHRF1 and other chromatin regulators.	RPL26 POLR2B ARHGEF12 PSMD4 RRM2 PRPF8 GTPBP10 CCT6A NSA2 GLG1 USP7 NOC4L ZFR CTNNB1 ZBTB11 HSPA6 HSPA8 RPL15	1.86e-07	971	148	18	33306668
Pubmed	Construction of long-transcript enriched cDNA libraries from submicrogram amounts of total RNAs by a universal PCR amplification method.	HDAC6 ARHGAP15 RAPGEF5 POLR2B DHX38 PTPN23 ZNF496 TRIP12 PRDM2 TTBK2 INTS14 ZNF780A ZNF341 NSA2 GLG1 ARID5B CEP295 ULK2 RPL15	1.95e-07	1084	148	19	11544199
Pubmed	Regulation and function of family 1 and family 2 UDP-glucuronosyltransferase genes (UGT1A, UGT2B) in human oesophagus.	UGT2B7 UGT2B10 UGT2B15	3.01e-07	4	148	3	10024527
Pubmed	Deacetylation of tumor-suppressor MST1 in Hippo pathway induces its degradation through HBXIP-elevated HDAC6 in promotion of breast cancer growth.	HDAC6 STK4 HSPA8	3.01e-07	4	148	3	26657153
Pubmed	Impacts of the Glucuronidase Genotypes UGT1A4, UGT2B7, UGT2B15 and UGT2B17 on Tamoxifen Metabolism in Breast Cancer Patients.	UGT2B7 UGT2B15 UGT2B17	3.01e-07	4	148	3	26176234
Pubmed	The Hsp70-Hsp90 co-chaperone Hop/Stip1 shifts the proteostatic balance from folding towards degradation.	POLR2B PTPN23 PSMD4 RRM2 PRPF8 GSPT1 CCT6A USP7 NOC4L CTNNB1 HSPA6 VARS1 HSPA8 RPL15	6.55e-07	638	148	14	33239621
Pubmed	Combinatorial targeting of a chromatin complex comprising Dot1L, menin and the tyrosine kinase BAZ1B reveals a new therapeutic vulnerability of endocrine therapy-resistant breast cancer.	CDK9 RPL26 DHX38 RCN1 PRPF8 TRIP12 ZFY CCT6A NSA2 RPL26L1 PUM3 DLST ZFR THRAP3 HSPA8 RPL15	7.31e-07	847	148	16	35850772
Pubmed	UDP-glucuronosyltransferase and sulfotransferase polymorphisms, sex hormone concentrations, and tumor receptor status in breast cancer patients.	UGT2B4 UGT2B7 UGT2B15	7.50e-07	5	148	3	15318931
Pubmed	In-Depth In Vivo Crosslinking in Minutes by a Compact, Membrane-Permeable, and Alkynyl-Enrichable Crosslinker.	RPL26 ACACB PPFIA4 RCN1 PRPF8 TRIP12 GSPT1 CCT6A C6orf118 LATS1 NSA2 RPL26L1 DLST ZFR CEP295 ZBTB11 HSPA6 VARS1 THRAP3 HSPA8 ZNF541	8.80e-07	1442	148	21	35575683
Pubmed	A GO catalogue of human DNA-binding transcription factors.	ZNF155 ZNF576 ZNF469 ZNF654 ZNF222	9.77e-07	42	148	5	34673265
Pubmed	Neuron-specific protein network mapping of autism risk genes identifies shared biological mechanisms and disease-relevant pathologies.	TNIK DOCK4 GAD1 ACACB DGKG PSMD4 ADAM22 CACNG2 CCT6A GLG1 USP7 DLST CRYBG3 CTNNB1 VARS1 THRAP3 HSPA8 RPL15	1.84e-06	1139	148	18	36417873
Pubmed	Anticancer sulfonamides target splicing by inducing RBM39 degradation via recruitment to DCAF15.	POLR2B DHX38 RCN1 RRM2 PRPF8 CCT6A RPL26L1 PUM3 DLST ZFR VARS1 THRAP3 HSPA8 RPL15	2.44e-06	714	148	14	28302793
Pubmed	H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids.	RPL26 ZBTB20 POLR2B DHX38 PRPF8 TRIP12 PRDM2 ZFX ZBTB44 INTS14 KANSL2 ZNF276 ARID5B USP7 ZFR HSPA6 THRAP3 HSPA8 RPL15	2.72e-06	1294	148	19	30804502
Pubmed	Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation.	POLR2B DHX38 KIAA0586 PSMD4 PRPF8 PRDM2 GSPT1 PIK3R4 CCT6A GUCY1B2 RPL26L1 USP7 NOC4L PUM3 DLST ZFR VARS1 THRAP3 HSPA8 RPL15	2.87e-06	1425	148	20	30948266
Pubmed	Requirement for a kinase-specific chaperone pathway in the production of a Cdk9/cyclin T1 heterodimer responsible for P-TEFb-mediated tat stimulation of HIV-1 transcription.	CDK9 POLR2B HSPA6 HSPA8	3.13e-06	24	148	4	10617616
Pubmed	Paralog knockout profiling identifies DUSP4 and DUSP6 as a digenic dependence in MAPK pathway-driven cancers.	CDK9 ZBTB20 CAMK1D ADAM21 POLR2B DGKB GSPT1 STK4 LATS1 FGR KAT6B MAP2K1 ULK2 THRAP3	3.15e-06	730	148	14	34857952
Pubmed	Physiological and pathophysiological characteristics of ataxin-3 isoforms.	PSMD4 PRPF8 CCT6A USP7 DLST HSPA6 VARS1 HSPA8 RPL15	3.55e-06	281	148	9	30455355
Pubmed	Simultaneous evaluation of six human glucuronidation activities in liver microsomes using liquid chromatography-tandem mass spectrometry.	UGT2B7 UGT2B15 UGT2B17	4.16e-06	8	148	3	22579593
Pubmed	The functional interactome landscape of the human histone deacetylase family.	HDAC6 POLR2B RCN1 CCT6A BCL11B ARID5B USP7 ZFR THRAP3	4.46e-06	289	148	9	23752268
Pubmed	ZBTB20 is crucial for the specification of a subset of callosal projection neurons and astrocytes in the mammalian neocortex.	ZBTB20 ZBTB49 ZBTB44 BCL11B ZBTB11	7.51e-06	63	148	5	34351428
Pubmed	USP7 targets XIAP for cancer progression: Establishment of a p53-independent therapeutic avenue for glioma.	ACACB PRPF8 TRIP12 FAT2 USP7 DLST VARS1 THRAP3	7.82e-06	234	148	8	36243803
Pubmed	The cellular EJC interactome reveals higher-order mRNP structure and an EJC-SR protein nexus.	DOCK4 RPL26 PRPF8 RPL26L1 THRAP3 HSPA8 RPL15	8.49e-06	169	148	7	23084401
Pubmed	Functional specialization of beta-arrestin interactions revealed by proteomic analysis.	RPL26 ARHGEF12 DGKG CCT6A HSPA6 HSPA7 THRAP3 HSPA8 RPL15	9.38e-06	317	148	9	17620599
Pubmed	Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones.	CDK9 RPL26 HDAC6 POLR2B DHX38 RCN1 PTPN23 PRPF8 GTPBP10 GSPT1 CCT6A GLG1 USP7 CTH HSPA6 VARS1 THRAP3 HSPA8 RPL15	9.73e-06	1415	148	19	28515276
Pubmed	USP7 Regulates Cytokinesis through FBXO38 and KIF20B.	TRIP12 ZNF780A ARID5B USP7 NOC4L HSPA6	1.08e-05	116	148	6	30804394
Pubmed	TBK1 phosphorylation activates LIR-dependent degradation of the inflammation repressor TNIP1.	RPL26 POLR2B PRPF8 NCCRP1 CCT6A NSA2 RPL26L1 USP7 ZFR HSPA6 HSPA7 VARS1 THRAP3 HSPA8 RPL15	1.40e-05	949	148	15	36574265
Pubmed	Protein kinase DYRK2 is a scaffold that facilitates assembly of an E3 ligase.	DLST HSPA6 HSPA8 DYRK2	1.49e-05	35	148	4	19287380
Pubmed	Tissue-Specific Regulation of the Wnt/β-Catenin Pathway by PAGE4 Inhibition of Tankyrase.	PSMD4 PRPF8 CCT6A RPL26L1 DLST THRAP3 HSPA8 RPL15	1.50e-05	256	148	8	32698014
Pubmed	Talpid3-Mediated Centrosome Integrity Restrains Neural Progenitor Delamination to Sustain Neurogenesis by Stabilizing Adherens Junctions.	KIAA0586 BCL11B CTNNB1	1.62e-05	12	148	3	33326788
Pubmed	Affinity purification reveals the association of WD40 protein constitutive photomorphogenic 1 with the hetero-oligomeric TCP-1 chaperonin complex in mammalian cells.	CCT6A HSPA6 HSPA8	1.62e-05	12	148	3	16497536
Pubmed	Detoxification enzyme polymorphisms are not involved in duodenal adenomatosis in familial adenomatous polyposis.	UGT2B4 UGT2B7 UGT2B15	1.62e-05	12	148	3	18161889
Pubmed	Quantitative Proteomics Reveals Dynamic Interactions of the Minichromosome Maintenance Complex (MCM) in the Cellular Response to Etoposide Induced DNA Damage.	RPL26 HDAC6 PRPF8 NCCRP1 TTBK2 CCT6A RPL26L1 CCT6B CTNNB1 HSPA6 HSPA7 THRAP3 HSPA8 RPL15	1.62e-05	844	148	14	25963833
Pubmed	Kelch Domain of Gigaxonin Interacts with Intermediate Filament Proteins Affected in Giant Axonal Neuropathy.	ARHGEF12 CCT6A ZNF469 CCT6B HSPA6 THRAP3 HSPA8	1.64e-05	187	148	7	26460568
Pubmed	A critical role for NF2 and the Hippo pathway in branching morphogenesis.	EPHB2 STK4 LATS1 CTNNB1	1.67e-05	36	148	4	27480037
Pubmed	DOCK4 promotes loss of proliferation in glioblastoma progenitor cells through nuclear beta-catenin accumulation and subsequent miR-302-367 cluster expression.	DOCK4 CTNNB1	1.80e-05	2	148	2	28925399
Pubmed	Expression of UDP-glucuronosyltransferases (UGTs) 2B7 and 1A6 in the human brain and identification of 5-hydroxytryptamine as a substrate.	UGT2B4 UGT2B7	1.80e-05	2	148	2	10222050
Pubmed	Expression of UDP Glucuronosyltransferases 2B15 and 2B17 is associated with methylation status in prostate cancer cells.	UGT2B15 UGT2B17	1.80e-05	2	148	2	32660355
Pubmed	Glucuronidation genotypes and nicotine metabolic phenotypes: importance of functional UGT2B10 and UGT2B17 polymorphisms.	UGT2B10 UGT2B17	1.80e-05	2	148	2	20876810
Pubmed	Zfa is an expressed retroposon derived from an alternative transcript of the Zfx gene.	ZFX ZFY	1.80e-05	2	148	2	1691708
Pubmed	The structure of the Zfx gene on the mouse X chromosome.	ZFX ZFY	1.80e-05	2	148	2	8188262
Pubmed	Identification and validation of the microRNA response elements in the 3'-untranslated region of the UDP glucuronosyltransferase (UGT) 2B7 and 2B15 genes by a functional genomics approach.	UGT2B7 UGT2B15	1.80e-05	2	148	2	28962835
Pubmed	Mapping the human ZFX locus to Xp21.3 by in situ hybridization.	ZFX ZFY	1.80e-05	2	148	2	2497060
Pubmed	Comparison of ZFY and ZFX gene structure and analysis of alternative 3' untranslated regions of ZFY.	ZFX ZFY	1.80e-05	2	148	2	2041734
Pubmed	Gene expression, X-inactivation, and methylation during spermatogenesis: the case of Zfa, Zfx, and Zfy in mice.	ZFX ZFY	1.80e-05	2	148	2	8318216
Pubmed	The UDP glucuronosyltransferase gene superfamily: suggested nomenclature based on evolutionary divergence.	UGT2B15 UGT2B17	1.80e-05	2	148	2	1909870
Pubmed	Androgen glucuronidation: an unexpected target for androgen deprivation therapy, with prognosis and diagnostic implications.	UGT2B15 UGT2B17	1.80e-05	2	148	2	24121496
Pubmed	[Expression of Zfx in mouse testicular spermatogenic cells].	ZFX ZFY	1.80e-05	2	148	2	38602753
Pubmed	Downregulation of STK4 promotes colon cancer invasion/migration through blocking β-catenin degradation.	STK4 CTNNB1	1.80e-05	2	148	2	32741119
Pubmed	Substrate specificity of the human UDP-glucuronosyltransferase UGT2B4 and UGT2B7. Identification of a critical aromatic amino acid residue at position 33.	UGT2B4 UGT2B7	1.80e-05	2	148	2	17263731
Pubmed	Novel associations of UDP-glucuronosyltransferase 2B gene variants with prostate cancer risk in a multiethnic study.	UGT2B15 UGT2B17	1.80e-05	2	148	2	24267955
Pubmed	Differential expression of the androgen-conjugating UGT2B15 and UGT2B17 enzymes in prostate tumor cells during cancer progression.	UGT2B15 UGT2B17	1.80e-05	2	148	2	22170718
Pubmed	Differential rates of evolution for the ZFY-related zinc finger genes, Zfy, Zfx, and Zfa in the mouse genus Mus.	ZFX ZFY	1.80e-05	2	148	2	12716983
Pubmed	Intron/exon structure confirms that mouse Zfy1 and Zfy2 are members of the ZFY gene family.	ZFX ZFY	1.80e-05	2	148	2	9126493
Pubmed	Identification of Glis1, a novel Gli-related, Kruppel-like zinc finger protein containing transactivation and repressor functions.	GLIS3 GLIS1	1.80e-05	2	148	2	12042312
Pubmed	Glucuronidation of trans-3'-hydroxycotinine by UGT2B17 and UGT2B10.	UGT2B10 UGT2B17	1.80e-05	2	148	2	22228205
Pubmed	Evolution of the Zfx and Zfy genes: rates and interdependence between the genes.	ZFX ZFY	1.80e-05	2	148	2	8487630
Pubmed	Single nucleotide polymorphisms and haplotype frequencies of UGT2B4 and UGT2B7 in a Japanese population.	UGT2B4 UGT2B7	1.80e-05	2	148	2	15319348
Pubmed	Localization of UDP glucuronosyltransferase gene(s) on mouse chromosome 5.	UGT2B15 UGT2B17	1.80e-05	2	148	2	3105095
Pubmed	UDP-glucuronosyltransferase 2B15 (UGT2B15) and UGT2B17 enzymes are major determinants of the androgen response in prostate cancer LNCaP cells.	UGT2B15 UGT2B17	1.80e-05	2	148	2	17848572
Pubmed	Androgen and Estrogen Receptors in Breast Cancer Coregulate Human UDP-Glucuronosyltransferases 2B15 and 2B17.	UGT2B15 UGT2B17	1.80e-05	2	148	2	27496708
Pubmed	Zfx mutation results in small animal size and reduced germ cell number in male and female mice.	ZFX ZFY	1.80e-05	2	148	2	9187153
Pubmed	Regional assignments of the zinc finger Y-linked gene (ZFY) and related sequences on human and mouse chromosomes.	ZFX ZFY	1.80e-05	2	148	2	2265557
Pubmed	The uridine diphosphate glucuronosyltransferase 2B15 D85Y and 2B17 deletion polymorphisms predict the glucuronidation pattern of androgens and fat mass in men.	UGT2B15 UGT2B17	1.80e-05	2	148	2	17698910
Pubmed	The human heat-shock genes HSPA6 and HSPA7 are both expressed and localize to chromosome 1.	HSPA6 HSPA7	1.80e-05	2	148	2	1346391
Pubmed	Expression of phosphorylated Hippo pathway kinases (MST1/2 and LATS1/2) in HER2-positive and triple-negative breast cancer patients treated with neoadjuvant therapy.	STK4 LATS1	1.80e-05	2	148	2	28387539
Pubmed	Trip12 is an E3 ubiquitin ligase for USP7/HAUSP involved in the DNA damage response.	TRIP12 USP7	1.80e-05	2	148	2	27800609
Pubmed	MicroRNA-1826 directly targets beta-catenin (CTNNB1) and MEK1 (MAP2K1) in VHL-inactivated renal cancer.	CTNNB1 MAP2K1	1.80e-05	2	148	2	22180573
Pubmed	Sodium-calcium exchanger-3 regulates pain "wind-up": From human psychophysics to spinal mechanisms.	GAD1 SLC8A3	1.80e-05	2	148	2	35705078
Pubmed	Mouse Zfx protein is similar to Zfy-2: each contains an acidic activating domain and 13 zinc fingers.	ZFX ZFY	1.80e-05	2	148	2	2105457
Pubmed	Pharmacokinetic and pharmacodynamic interaction of lorazepam and valproic acid in relation to UGT2B7 genetic polymorphism in healthy subjects.	UGT2B7 UGT2B15	1.80e-05	2	148	2	17687269
Pubmed	Mouse UDP glucuronosyltransferase. cDNA and complete amino acid sequence and regulation.	UGT2B15 UGT2B17	1.80e-05	2	148	2	3117546
Pubmed	Transcription factor Zfx controls BCR-induced proliferation and survival of B lymphocytes.	ZFX ZFY	1.80e-05	2	148	2	19329779
Pubmed	Chromosomal localization of ZFX--a human gene that escapes X inactivation--and its murine homologs.	ZFX ZFY	1.80e-05	2	148	2	1970799
Pubmed	The UGT2A1/UGT2A2 locus is associated with COVID-19-related loss of smell or taste.	UGT2A2 UGT2A1	1.80e-05	2	148	2	35039640
Pubmed	Comparison of human ZFY and ZFX transcripts.	ZFX ZFY	1.80e-05	2	148	2	2308929
Pubmed	RNAi as a tool to control the sex ratio of mouse offspring by interrupting Zfx/Zfy genes in the testis.	ZFX ZFY	1.80e-05	2	148	2	28251288
Pubmed	Rat olfactory bulb and epithelium UDP-glucuronosyltransferase 2A1 (UGT2A1) expression: in situ mRNA localization and quantitative analysis.	UGT2A2 UGT2A1	1.80e-05	2	148	2	11376859
Pubmed	Comprehensive Characterization of Mouse UDP-Glucuronosyltransferase (Ugt) Belonging to the Ugt2b Subfamily: Identification of Ugt2b36 as the Predominant Isoform Involved in Morphine Glucuronidation.	UGT2B15 UGT2B17	1.80e-05	2	148	2	28228532
Pubmed	Circ_0000520 contributes to triple-negative breast cancer progression through mediating the miR-1296/ZFX axis.	ZFX ZFY	1.80e-05	2	148	2	34324278
Pubmed	Cloning and characterization of a novel human olfactory UDP-glucuronosyltransferase.	UGT2A2 UGT2A1	1.80e-05	2	148	2	10359671
Pubmed	Cellular specific expression of the androgen-conjugating enzymes UGT2B15 and UGT2B17 in the human prostate epithelium.	UGT2B15 UGT2B17	1.80e-05	2	148	2	15666817
Pubmed	RRM2 Is a CTNNB1 Transport Regulator Promoting Colon Cancer Progression.	RRM2 CTNNB1	1.80e-05	2	148	2	38821625
Pubmed	Global mapping of herpesvirus-host protein complexes reveals a transcription strategy for late genes.	TRPM7 POLR2B RCN1 GTPBP10 NSA2 GLG1 USP7 PUM3 DLST HSPA7 THRAP3	1.91e-05	533	148	11	25544563
Pubmed	Coordinated regulation of the ribosome and proteasome by PRMT1 in the maintenance of neural stemness in cancer cells and neural stem cells.	RPL26 PSMD4 USP7	2.09e-05	13	148	3	34619150
Pubmed	The Hippo pathway regulates Wnt/beta-catenin signaling.	STK4 LATS1 CTNNB1	2.09e-05	13	148	3	20412773
Interaction	RPL7A interactions	CDK9 RPL26 HDAC6 MKNK2 ATP9A PRPF8 TRIP12 GTPBP10 GSPT1 FAT2 KBTBD4 NSA2 RPL26L1 USP7 PUM3 CTNNB1 MAP2K1 PRDM15 HSPA8 RPL15 DYRK2	1.10e-08	679	141	21	int:RPL7A
Interaction	RPS6 interactions	CDK9 ERICH1 RPL26 HDAC6 ACACB PSMD4 PRPF8 GSPT1 KBTBD4 NSA2 RPL26L1 USP7 NOC4L PUM3 ZFR CTNNB1 ZBTB11 MAP2K1 PRDM15 VARS1 HSPA8 RPL15	1.81e-07	874	141	22	int:RPS6
Interaction	RPL30 interactions	CDK9 RPL26 HDAC6 PRPF8 GSPT1 PIK3R4 NSA2 GLG1 RPL26L1 PUM3 DLST CTNNB1 ZBTB11 PRDM15 RPL15	1.22e-06	474	141	15	int:RPL30
Interaction	RPL31 interactions	CDK9 RPL26 HDAC6 PSMD4 PRPF8 ZFX GSPT1 BLVRB NSA2 RPL26L1 NOC4L PUM3 ZFR CTNNB1 ZBTB11 PRDM15 HSPA8 RPL15	1.30e-06	680	141	18	int:RPL31
Interaction	RPL7 interactions	CDK9 RPL26 HDAC6 PRPF8 PIK3R4 KBTBD4 NSA2 RPL26L1 NOC4L ZBTB11 MAP2K1 VARS1 HSPA8 RPL15 DYRK2	1.88e-06	491	141	15	int:RPL7
Interaction	EEF1D interactions	CDK9 HDAC6 PRPF8 CCT6A USP7 DLST CTNNB1 MAP2K1 VARS1 THRAP3 HSPA8 RPL15	4.03e-06	333	141	12	int:EEF1D
Interaction	PXN interactions	DOCK4 HDAC6 TTC28 ARHGEF12 PTPN23 USP7 CRYBG3 CTNNB1 MAP2K1 HSPA6 HSPA7 HSPA8	4.15e-06	334	141	12	int:PXN
Interaction	NOP2 interactions	CDK9 RPL26 HDAC6 PRPF8 GTPBP10 LATS1 NSA2 RPL26L1 USP7 PUM3 MAP2K1 HSPA8 RPL15	7.42e-06	416	141	13	int:NOP2
Interaction	RPL13 interactions	CDK9 RPL26 HDAC6 PRPF8 GTPBP10 GSPT1 KBTBD4 NSA2 RPL26L1 PUM3 ZFR CTNNB1 ZBTB11 PRDM15 HSPA8 RPL15 DYRK2	8.21e-06	700	141	17	int:RPL13
Interaction	LARP7 interactions	CDK9 RPL26 DHX38 PSMD4 PRPF8 ZFX CCT6A RPL26L1 CCT6B NOC4L PUM3 ZFR FGR ZBTB11 PRDM15 HSPA6 HSPA7 VARS1 THRAP3 HSPA8 RPL15 DYRK2	9.66e-06	1113	141	22	int:LARP7
Interaction	DOCK5 interactions	CDK9 HDAC6 ACACB TTC28 RAPGEF5 HSPA8 MOCOS	1.31e-05	111	141	7	int:DOCK5
Interaction	RPL11 interactions	RPL26 HDAC6 PSMD4 PRPF8 TRIP12 GSPT1 NSA2 RPL26L1 PUM3 ZFR CTNNB1 ZBTB11 PRDM15 THRAP3 HSPA8 RPL15	1.36e-05	652	141	16	int:RPL11
Interaction	RPLP0 interactions	CDK9 RPL26 HDAC6 PRPF8 GTPBP10 GSPT1 NSA2 RPL26L1 USP7 PUM3 CTNNB1 ZBTB11 PRDM15 HSPA8 RPL15 DYRK2	1.58e-05	660	141	16	int:RPLP0
Interaction	IFIT1B interactions	DHX38 IFIT1B MOCOS	1.83e-05	8	141	3	int:IFIT1B
Interaction	WDR5B interactions	ACACB SELENON CCT6A CCT6B HSPA8	2.57e-05	50	141	5	int:WDR5B
Interaction	OASL interactions	CCT6A NSA2 RPL26L1 NOC4L PUM3 ZFR ZBTB11 PRDM15 HSPA6	2.80e-05	223	141	9	int:OASL
Interaction	USP15 interactions	DOCK4 RPL26 GAD1 MKNK2 DGKG PSMD4 GSPT1 LATS1 KBTBD4 USP7 CTNNB1 VARS1 HSPA8 RPL15	3.01e-05	546	141	14	int:USP15
Interaction	FBXO45 interactions	EPHB2 TNIK ABCA2 CCT6A ZNF780A CTNNB1	3.57e-05	88	141	6	int:FBXO45
Interaction	PRR11 interactions	NSA2 RPL26L1 NOC4L PUM3 ZBTB11 PRDM15 RPL15	3.65e-05	130	141	7	int:PRR11
Interaction	CAD interactions	CDK9 TNIK HDAC6 PTPN23 PSMD4 CCT6A LATS1 CTNNB1 FGR MAP2K1 VARS1 HSPA8	3.88e-05	418	141	12	int:CAD
Interaction	MCM5 interactions	HDAC6 POLR2B PSMD4 PRPF8 GSPT1 INTS14 USP7 CTNNB1 HSPA6 HSPA7 THRAP3 HSPA8	4.06e-05	420	141	12	int:MCM5
Interaction	KLHL33 interactions	CCT6A USP7 CCT6B HSPA8	4.13e-05	28	141	4	int:KLHL33
Interaction	RPS19 interactions	CDK9 RPL26 HDAC6 PRPF8 GSPT1 NSA2 RPL26L1 NOC4L ZFR ZBTB11 PRDM15 VARS1 THRAP3 HSPA8 RPL15	4.27e-05	639	141	15	int:RPS19
Interaction	RAP2A interactions	TNIK CTU2 HDAC6 RAPGEF5 CCT6A MOCOS	4.31e-05	91	141	6	int:RAP2A
Interaction	ABT1 interactions	HDAC6 TRIP12 GTPBP10 STK4 NSA2 RPL26L1 NOC4L PUM3 ZFR ZBTB11 PRDM15 RPL15	4.35e-05	423	141	12	int:ABT1
Interaction	RPL28 interactions	CDK9 RPL26 HDAC6 GTPBP10 KBTBD4 NSA2 RPL26L1 PUM3 CEP295 CTNNB1 PRDM15 HSPA8 RPL15	4.49e-05	494	141	13	int:RPL28
Interaction	RPS16 interactions	CDK9 RPL26 HDAC6 PRPF8 GSPT1 KBTBD4 NSA2 RPL26L1 NOC4L ZFR CTNNB1 ZBTB11 PRDM15 HSPA8 RPL15 DYRK2	4.82e-05	724	141	16	int:RPS16
Interaction	RPS2 interactions	CDK9 RPL26 HDAC6 PRPF8 ZNF496 GSPT1 NSA2 RPL26L1 ZFR CTNNB1 ZBTB11 VARS1 HSPA8 RPL15 DYRK2	5.85e-05	657	141	15	int:RPS2
Interaction	RPL13A interactions	RPL26 HDAC6 PRPF8 GTPBP10 GSPT1 KBTBD4 NSA2 RPL26L1 PUM3 ZBTB11 PRDM15 HSPA8 ZNF541 RPL15	7.06e-05	591	141	14	int:RPL13A
Interaction	RBM4 interactions	RPL26 MKNK2 TRIP12 GSPT1 KBTBD4 NSA2 RPL26L1 PUM3 DLST RPL15	8.50e-05	319	141	10	int:RBM4
Interaction	RPL4 interactions	CDK9 RPL26 HDAC6 PRPF8 TRIP12 GTPBP10 GSPT1 KBTBD4 NSA2 RPL26L1 PUM3 CTNNB1 ZBTB11 PRDM15 RPL15 DYRK2	9.07e-05	764	141	16	int:RPL4
Interaction	MAGOH interactions	DOCK4 RPL26 PRPF8 GSPT1 RPL26L1 THRAP3 HSPA8 RPL15 DYRK2	1.03e-04	264	141	9	int:MAGOH
Interaction	GRIN1 interactions	EPHB2 TNIK CACNG2 BCL11B CTNNB1 MAP2K1 HSPA8	1.07e-04	154	141	7	int:GRIN1
Interaction	RPL8 interactions	RPL26 HDAC6 PRPF8 GSPT1 NSA2 RPL26L1 PUM3 CTNNB1 ZBTB11 MAP2K1 PRDM15 HSPA8 RPL15	1.08e-04	539	141	13	int:RPL8
Interaction	FAM83F interactions	CCT6A CCT6B HSPA6 HSPA8	1.14e-04	36	141	4	int:FAM83F
Interaction	LFNG interactions	CCT6A CCT6B HSPA8	1.15e-04	14	141	3	int:LFNG
Interaction	AKAP12 interactions	HDAC6 STK4 KBTBD4 CTNNB1 MAP2K1 HSPA8 DYRK2	1.16e-04	156	141	7	int:AKAP12
Interaction	RSL1D1 interactions	RPL26 HDAC6 LATS1 NSA2 RPL26L1 USP7 NOC4L PUM3 CEP295 ZBTB11 PRDM15 HSPA8	1.41e-04	479	141	12	int:RSL1D1
Interaction	UGT2A1 interactions	UGT2A1 UGT2B15	1.45e-04	3	141	2	int:UGT2A1
Interaction	DDX21 interactions	CDK9 RPL26 HDAC6 PRPF8 GTPBP10 KBTBD4 NSA2 RPL26L1 USP7 PUM3 DLST ZFR THRAP3 HSPA8 RPL15	1.56e-04	718	141	15	int:DDX21
Interaction	RPL3 interactions	RPL26 HDAC6 PRPF8 TRIP12 GTPBP10 GSPT1 KBTBD4 NSA2 RPL26L1 PUM3 CTNNB1 ZBTB11 PRDM15 HSPA8 RPL15	1.66e-04	722	141	15	int:RPL3
Interaction	RBM19 interactions	RPL26 NSA2 RPL26L1 NOC4L PUM3 ZBTB11 HSPA8 RPL15	1.67e-04	221	141	8	int:RBM19
Interaction	DOT1L interactions	CDK9 RPL26 RCN1 PRPF8 TRIP12 CCT6A INTS14 NSA2 RPL26L1 PUM3 DLST ZFR CTNNB1 THRAP3 HSPA8 RPL15	1.70e-04	807	141	16	int:DOT1L
Interaction	ADARB1 interactions	RPL26 GTPBP10 NSA2 RPL26L1 USP7 NOC4L PUM3 ZFR ZBTB11 VARS1 HSPA8 RPL15	1.71e-04	489	141	12	int:ADARB1
Interaction	RPL10A interactions	CDK9 RPL26 HDAC6 PRPF8 GTPBP10 GSPT1 NSA2 RPL26L1 PUM3 CTNNB1 HSPA8 RPL15	1.74e-04	490	141	12	int:RPL10A
Interaction	MAGEB2 interactions	RPL26 GTPBP10 NSA2 RPL26L1 USP7 PUM3 ZFR ZBTB11 PRDM15 RPL15	1.77e-04	349	141	10	int:MAGEB2
Interaction	PURG interactions	GTPBP10 NSA2 RPL26L1 NOC4L PUM3 ZFR ZBTB11 PRDM15	1.78e-04	223	141	8	int:PURG
Interaction	RPL26 interactions	RPL26 HDAC6 PRPF8 NSA2 RPL26L1 USP7 PUM3 ZBTB11 PRDM15 HSPA8 RPL15	1.80e-04	419	141	11	int:RPL26
Interaction	IMPDH2 interactions	HDAC6 TTC28 ARHGEF12 PTPN23 PSMD4 GSPT1 DLST CRYBG3 CTNNB1 HSPA8 RPL15	1.84e-04	420	141	11	int:IMPDH2
Interaction	PELI3 interactions	CCT6A CCT6B HSPA6 HSPA8	1.90e-04	41	141	4	int:PELI3
Interaction	RPS3A interactions	CDK9 RPL26 HDAC6 PRPF8 GSPT1 NSA2 RPL26L1 NOC4L PUM3 CTNNB1 VARS1 THRAP3 HSPA8 RPL15	2.07e-04	655	141	14	int:RPS3A
Interaction	MATR3 interactions	CDK9 TNIK HDAC6 RCN1 PRPF8 LATS1 KBTBD4 RPL26L1 USP7 ZFR CTNNB1 THRAP3 HSPA8 RPL15	2.07e-04	655	141	14	int:MATR3
Interaction	CDK7 interactions	CDK9 ACACB POLR2B DHX38 PSMD4 BCL11B EXOC6B DLST HSPA6 THRAP3 HSPA8 RPL15	2.14e-04	501	141	12	int:CDK7
Interaction	RNF151 interactions	NSA2 RPL26L1 PUM3 ZBTB11 PRDM15 RPL15	2.29e-04	123	141	6	int:RNF151
Interaction	ELK1 interactions	CDK9 CTNNB1 MAP2K1 HSPA6 HSPA7 HSPA8	2.50e-04	125	141	6	int:ELK1
Interaction	TSSK1B interactions	CRYBG3 CTNNB1 HSPA6 HSPA8	2.51e-04	44	141	4	int:TSSK1B
Interaction	RPS20 interactions	CDK9 DOCK4 RPL26 HDAC6 DHX38 PSMD4 PRPF8 GSPT1 EXOC6B CTNNB1 HSPA8 RPL15	2.65e-04	513	141	12	int:RPS20
Interaction	FRMD8P1 interactions	HSPA6 HSPA8	2.89e-04	4	141	2	int:FRMD8P1
Interaction	USP36 interactions	DOCK4 RPL26 PSMD4 PRPF8 ZBTB44 NSA2 USP7 NOC4L PUM3 ZFR CTNNB1 HSPA8 RPL15	3.03e-04	599	141	13	int:USP36
Interaction	MEN1 interactions	CDK9 RPL26 POLR2B DHX38 PRPF8 TRIP12 ZFY KANSL2 NSA2 RPL26L1 PUM3 DLST ZFR CTNNB1 KAT6B THRAP3 HSPA8 RPL15	3.08e-04	1029	141	18	int:MEN1
Interaction	RPSA interactions	CDK9 RPL26 HDAC6 PRPF8 GSPT1 CCT6A RPL26L1 CTNNB1 ZBTB11 PRDM15 HSPA8 RPL15	3.11e-04	522	141	12	int:RPSA
Interaction	RPL18A interactions	CDK9 RPL26 HDAC6 PRPF8 NSA2 RPL26L1 PUM3 CTNNB1 VARS1 HSPA8 RPL15	3.14e-04	447	141	11	int:RPL18A
Interaction	TSSK6 interactions	POLR2B CCT6A THRAP3 HSPA8	3.24e-04	47	141	4	int:TSSK6
Interaction	KRR1 interactions	RPL26 TRIP12 ZFX NSA2 RPL26L1 NOC4L PUM3 ZBTB11 MAP2K1 RPL15	3.42e-04	379	141	10	int:KRR1
Interaction	RPS14 interactions	RPL26 HDAC6 PRPF8 GSPT1 KBTBD4 NSA2 RPL26L1 NOC4L PUM3 CTNNB1 HSPA8 RPL15	3.50e-04	529	141	12	int:RPS14
Interaction	RBM39 interactions	CDK9 HDAC6 POLR2B DHX38 RCN1 RRM2 PRPF8 CCT6A RPL26L1 USP7 PUM3 DLST ZFR CTNNB1 VARS1 THRAP3 HSPA8 RPL15	3.58e-04	1042	141	18	int:RBM39
Interaction	PRKCI interactions	ABHD10 DHX38 TRIP12 GSPT1 USP7 MAP2K1 HSPA6 HSPA7 HSPA8	3.66e-04	313	141	9	int:PRKCI
Interaction	UBD interactions	HDAC6 PSMD4 USP7 CTNNB1	3.81e-04	49	141	4	int:UBD
Interaction	PDGFB interactions	NSA2 RPL26L1 NOC4L PUM3 RPL15	3.84e-04	88	141	5	int:PDGFB
Interaction	SRPK3 interactions	RPL26 NSA2 RPL26L1 PUM3 PRDM15 THRAP3 RPL15	3.87e-04	190	141	7	int:SRPK3
Interaction	ZNF488 interactions	CTH HSPA6 HSPA8	4.07e-04	21	141	3	int:ZNF488
Interaction	PAGE4 interactions	PSMD4 PRPF8 CCT6A RPL26L1 DLST THRAP3 HSPA8 RPL15	4.16e-04	253	141	8	int:PAGE4
Interaction	MYBBP1A interactions	RPL26 HDAC6 PRPF8 LATS1 NSA2 RPL26L1 USP7 PUM3 CTNNB1 HSPA8 RPL15	4.22e-04	463	141	11	int:MYBBP1A
Interaction	EEF1G interactions	RPL26 HDAC6 PSMD4 PRPF8 PIK3R4 RPL26L1 USP7 DLST VARS1 THRAP3 HSPA8	4.22e-04	463	141	11	int:EEF1G
Interaction	GSK3A interactions	TNIK HDAC6 ACACB TTC28 MKNK2 KIAA0586 ARHGEF12 CRYBG3 CTNNB1 THRAP3 RPL15	4.30e-04	464	141	11	int:GSK3A
Interaction	CIT interactions	CDK9 TNIK RPL26 GAD1 POLR2B DHX38 RCN1 PRPF8 TRIP12 OR1D2 CCT6A NSA2 RPL26L1 NOC4L PUM3 ZFR CTNNB1 HSPA6 HSPA7 THRAP3 HSPA8 RPL15	4.67e-04	1450	141	22	int:CIT
Interaction	PRKRA interactions	RPL26 TRIP12 GTPBP10 NSA2 RPL26L1 PUM3 ZBTB11 PRDM15 HSPA8 RPL15	5.22e-04	400	141	10	int:PRKRA
Interaction	RBM4B interactions	NSA2 RPL26L1 NOC4L PUM3 ZFR ZBTB11 PRDM15 RPL15	5.24e-04	262	141	8	int:RBM4B
Interaction	HECTD1 interactions	EPHB2 RPL26 CTU2 TTC28 POLR2B PRPF8 TRIP12 GTPBP10 PIK3R4 NSA2 CCT6B NOC4L PUM3 DLST ZFR CTNNB1 ZBTB11	5.26e-04	984	141	17	int:HECTD1
Interaction	CRBN interactions	RPL26 HDAC6 GSPT1 CCT6A CLCN1 RPL26L1 CTNNB1	5.26e-04	200	141	7	int:CRBN
Cytoband	4q13	UGT2A1 UGT2B4 UGT2B7 UGT2B15 UGT2B17	9.52e-10	15	148	5	4q13
Cytoband	Ensembl 112 genes in cytogenetic band chr4q13	UGT2A2 UGT2A1 UGT2B4 UGT2B7 UGT2B10 UGT2B15 UGT2B17	8.53e-07	157	148	7	chr4q13
Cytoband	19p13.2	MBD3L5 MBD3L2 MBD3L3 MBD3L4 ZNF441 MBD3L2B	1.05e-04	229	148	6	19p13.2
Cytoband	9p24.2	GLIS3 PUM3	5.57e-04	11	148	2	9p24.2
GeneFamily	Zinc fingers C2H2-type\|ZF class homeoboxes and pseudogenes	ZBTB20 ZNF155 ZNF780B GLIS3 ZNF576 ZNF496 ZNF416 ZNF441 ZFX ZFY ZBTB49 ZBTB44 ZNF469 ZNF276 BCL11B ZNF605 ZNF684 ZNF780A ZNF341 SP5 ZNF606 ZBTB11 PRDM15 GLIS1 ZNF541 ZNF222	8.00e-15	718	99	26	28
GeneFamily	UDP glucuronosyltransferases	UGT2A2 UGT2A1 UGT2B4 UGT2B7 UGT2B10 UGT2B15 UGT2B17	3.58e-10	32	99	7	363
GeneFamily	Heat shock 70kDa proteins	HSPA6 HSPA7 HSPA8	1.02e-04	17	99	3	583
GeneFamily	Myb/SANT domain containing\|NineTeen complex	CTNNB1 HSPA8	6.12e-04	7	99	2	1361
GeneFamily	Basic leucine zipper proteins\|BTB domain containing	ZBTB20 ZBTB49 ZBTB44 KBTBD4 ZBTB11	8.50e-04	134	99	5	861
GeneFamily	EF-hand domain containing\|Diacylglycerol kinases	DGKB DGKG	1.30e-03	10	99	2	1178
GeneFamily	L ribosomal proteins	RPL26 RPL26L1 RPL15	2.74e-03	51	99	3	729
GeneFamily	Chaperonins	CCT6A CCT6B	2.98e-03	15	99	2	587
GeneFamily	Zinc fingers C2H2-type\|PR/SET domain family	PRDM2 PRDM15	3.83e-03	17	99	2	1197
ToppCell	normal-na-Lymphocytic_T-T4_em-male\|normal / PBMC cell types (v2) per disease, treatment status, and sex	ERN1 ARHGAP15 ZFY STK4 FAT2 ARID5B KAT6B HSPA8	1.11e-07	171	148	8	61318a7aaf3bd8bdd28f8a8614ab4fdf2964b3a3
ToppCell	PCW_13-14\|World / Celltypes from embryonic and fetal-stage human lung	TNIK DOCK4 ZBTB20 ARHGAP15 ADAM22 ASPA CRYBG3 HSPA6	2.48e-07	190	148	8	62a3ec1ae0829602b0569cc051210551644f1d46
ToppCell	LPS-IL1RA+antiTNF-Myeloid-Dendritic_cells-Monocytes-Macrophages\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	EPHB2 CAMK1D ERN1 ARHGAP15 PPFIA4 FAT2 FGR	5.98e-07	146	148	7	b76110b159acd27a2c8d6a9f98336608ace1ec12
ToppCell	343B-Lymphocytic-CD4_T-cell\|343B / Donor, Lineage, Cell class and subclass (all cells)	RPL26 ARHGAP15 STK4 BCL11B ARID5B HSPA8 RPL15	3.01e-06	186	148	7	f6743d1f1d57d9d9a4581a88f156078a1da46816
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	TNIK ZBTB20 TTC28 GLIS3 UGT2B7 HYDIN GLIS1	3.59e-06	191	148	7	1cb02007adb344f17ef73d58890f91298c7cf5a1
ToppCell	356C-Lymphocytic-CD4_T-cell-CD4+_Naive_T_cell_/_CD4+_Trm_cell\|356C / Donor, Lineage, Cell class and subclass (all cells)	RPL26 ARHGAP15 STK4 BCL11B ARID5B HSPA8 RPL15	3.72e-06	192	148	7	7aa8585e08dfbee0acbaef5f8f3817ab3ab5af25
ToppCell	356C-Lymphocytic-CD4_T-cell\|356C / Donor, Lineage, Cell class and subclass (all cells)	RPL26 ARHGAP15 STK4 BCL11B ARID5B HSPA8 RPL15	3.72e-06	192	148	7	badf72a52eafb0269391d907ece6b1696684adce
ToppCell	nucseq\|World / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	DOCK4 ZBTB20 CAMK1D ARHGAP15 OOEP C9 MAP2K1	3.85e-06	193	148	7	779276e775cb2492e8dd36436295a536084a6415
ToppCell	3'_v3-blood-Lymphocytic_T_CD4-Teffector/EM_CD4\|blood / Manually curated celltypes from each tissue	RPL26 ARHGAP15 GSPT1 BCL11B ARID5B HSPA8 RPL15	3.98e-06	194	148	7	8499c03fa3d5cf9631b128681b13b7fc512b7e63
ToppCell	PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell\|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k)	TNIK ARHGAP15 GSPT1 BCL11B ARID5B HSPA8 DYRK2	3.98e-06	194	148	7	a44be2f021cfdd0fcdc698c3f04d66db7a1aa6c2
ToppCell	390C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_1.5\|CD8+_Cytotoxic_T-cell / Donor, Lineage, Cell class and subclass (all cells)	PROK2 DGKB OOEP PIK3R4 FGR CXCR1	1.24e-05	153	148	6	433b971c98da321204e065019db4e7825c7587cd
ToppCell	droplet-Liver-LIVER_HEP-30m-Myeloid-myeloid_leukocyte\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	EPHB2 GLIS3 DGKG NCCRP1 FGR ZNF385C	1.49e-05	158	148	6	91d265e95156f16459924d3e4dd11c180e164eee
ToppCell	droplet-Liver-LIVER_HEP-30m-Myeloid-macrophage/monocyte\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	EPHB2 GLIS3 DGKG NCCRP1 FGR ZNF385C	1.72e-05	162	148	6	93bd29c52846c3156b8b0d2e39c552373efdfe93
ToppCell	BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c02-GPR183\|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)	ARHGAP15 STK4 BCL11B KBTBD4 HTD2 HSPA8	2.65e-05	175	148	6	f456d8d958b71f7a942b718605712593d9de1bfd
ToppCell	5'-Adult-LargeIntestine-Hematopoietic-T_cells-Treg\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	TNIK PROK2 ARHGAP15 STK4 BCL11B ARID5B	3.20e-05	181	148	6	a6c8b33a392de3df2f179317e329e45d3d8c6f52
ToppCell	CF-Myeloid-Neutrophil\|CF / Disease state, Lineage and Cell class	PROK2 DOCK4 CAMK1D ARHGAP15 STK4 CXCR1	3.41e-05	183	148	6	da43827952e6fdee2ce94648c316182f272b321c
ToppCell	mild-Myeloid-Neutrophils_1\|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs	PROK2 DOCK4 CAMK1D ARHGAP15 HSPA6 CXCR1	3.51e-05	184	148	6	1a0e8b20b3ac8416d05c2d5934ab4ac80be4cce5
ToppCell	PBMC_fresh-frozen-Severe-critical_convalescent_d14-21-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c02-AQP3\|Severe-critical_convalescent_d14-21 / Compartment, severity and other cell annotations on 10x 3' data (130k)	TNIK ZBTB20 ERN1 ARHGAP15 TTC28 BCL11B	3.62e-05	185	148	6	e34473eea3a58c041183a4f52137366cd9489495
ToppCell	10x_3'_v3-tissue-resident_(10x_3'_v3)-hematologic\|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	IFIT1B UGT2B4 UGT2B7 UGT2B10 UGT2B15 C9	3.84e-05	187	148	6	edb0ab0154542b1c0b3a2c216c4a60f0f06290b3
ToppCell	RV-04._Ventricular_Cardiomyocyte_I\|World / Chamber and Cluster_Paper	TNIK ACACB TRPM7 DGKG CERS6 DGLUCY	3.84e-05	187	148	6	78cdcf8bc141d3b155c3c8af908431fc419c4d08
ToppCell	LV-04._Ventricular_Cardiomyocyte_I\|World / Chamber and Cluster_Paper	TNIK ACACB TRPM7 DGKG CERS6 DGLUCY	3.96e-05	188	148	6	0758b474457efa36488e0195f7357100f4b6a090
ToppCell	RV-06._Ventricular_Cardiomyocyte_II\|World / Chamber and Cluster_Paper	ACACB TRPM7 DGKG CERS6 DGLUCY EXOC6B	4.08e-05	189	148	6	5e80c47f63980904c4c1ff02c201b67b456a0974
ToppCell	10x_3'_v3-tissue-resident_(10x_3'_v3)-hematologic-erythrocytic\|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	IFIT1B UGT2B4 UGT2B7 UGT2B10 UGT2B15 C9	4.08e-05	189	148	6	7899af78b273d9c7f029d52f7e0cf6df4da41f5e
ToppCell	LV-06._Ventricular_Cardiomyocyte_II\|World / Chamber and Cluster_Paper	TNIK ACACB TRPM7 DGKG DGLUCY EXOC6B	4.20e-05	190	148	6	de5ef606a002f85c2e0e3a36c1f259d0b85a76ff
ToppCell	10x_3'_v3-tissue-resident_(10x_3'_v3)-hematologic-erythrocytic-erythrocyte\|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	IFIT1B UGT2B4 UGT2B7 UGT2B10 UGT2B15 C9	4.20e-05	190	148	6	a34293601aefe5fb5c400c14091294b9ddaa195b
ToppCell	RV-06._Ventricular_Cardiomyocyte_II\|RV / Chamber and Cluster_Paper	ACACB TRPM7 DGKG CERS6 DGLUCY EXOC6B	4.20e-05	190	148	6	fe8e78922c8ae928ef9a80bffd67868d5a87a091
ToppCell	control-Myeloid-Neutrophils_1\|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs	PROK2 DOCK4 CAMK1D ARHGAP15 HSPA6 CXCR1	4.32e-05	191	148	6	db1b3cd07d7d190155b2d14e82e1d124975fbd0b
ToppCell	LV-06._Ventricular_Cardiomyocyte_II\|LV / Chamber and Cluster_Paper	ACACB TRPM7 DGKG CERS6 DGLUCY EXOC6B	4.32e-05	191	148	6	25f3eb34f4e70761e81e84c8a5829f216108cbc6
ToppCell	343B-Lymphocytic-CD4_T-cell-CD4+_Naive_T_cell_/_CD4+_Trm_cell\|343B / Donor, Lineage, Cell class and subclass (all cells)	RPL26 ARHGAP15 BCL11B ARID5B HSPA8 RPL15	4.32e-05	191	148	6	0583a0db58197af609ae251dcf882fc48cd6c897
ToppCell	LV-04._Ventricular_Cardiomyocyte_I\|LV / Chamber and Cluster_Paper	TNIK ACACB TRPM7 DGKG CERS6 DGLUCY	4.45e-05	192	148	6	ad19e2c1d36a0566c9b12ced10db78f4781c8ea6
ToppCell	390C-Lymphocytic-CD4_T-cell-CD4+_Naive_T_cell_/_CD4+_Trm_cell\|390C / Donor, Lineage, Cell class and subclass (all cells)	RPL26 ARHGAP15 STK4 BCL11B ARID5B HSPA8	4.45e-05	192	148	6	494c5eca0f07fc761f26487a2b937c7056bbe594
ToppCell	10x_3'_v2v3-Non-neoplastic-Lymphoid-CD4/CD8-CD8_EM-G\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	RPL26 ERN1 ARHGAP15 STK4 BCL11B HSPA8	4.58e-05	193	148	6	465061688bc09c6d8adc2f662a385dab8918ebbf
ToppCell	mild-B_cell\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	ZBTB20 ACACB CRYBG3 ZNF606 KAT6B ZBTB11	4.85e-05	195	148	6	1e5f1967bcc898318f4e970b844b4a944eb168e5
ToppCell	systemic_lupus_erythematosus-managed-Lymphocytic_T-T4_em-male\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	RPL26 ARHGAP15 ZFY BCL11B ARID5B HSPA8	4.85e-05	195	148	6	48905d57775ec90cc031af0863cc8c3800f2e48e
ToppCell	facs-Bladder-nan-3m\|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ZBTB20 RCN1 SELENON TRIP12 GLG1 RPL15	4.99e-05	196	148	6	44f5b1b474399c9316729155f2ea95a82ca66e30
ToppCell	severe-Lymphocytic-CD4_T_cells_2\|severe / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs	RPL26 BCL11B NSA2 HSPA8 RPL15 DYRK2	4.99e-05	196	148	6	1b06639b7d2b81a1e5bcc455f3adda039f42ba57
ToppCell	3'_v3-blood-Lymphocytic_T_CD4\|blood / Manually curated celltypes from each tissue	RPL26 GSPT1 BCL11B NSA2 ARID5B RPL15	4.99e-05	196	148	6	05c2ad461a3c093ede4af677a61f9132e525e0b5
ToppCell	facs-Bladder-nan-3m-Epithelial\|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ZBTB20 RCN1 SELENON TRIP12 GLG1 RPL15	4.99e-05	196	148	6	c0e90d964baa2eb4fbd18a52379ccec5d3bf59a8
ToppCell	normal_Pleural_Fluid-T/NK_cells-Naive_CD4+_T\|normal_Pleural_Fluid / Location, Cell class and cell subclass	RPL26 ARHGAP15 BCL11B ARID5B HSPA8 RPL15	5.14e-05	197	148	6	05cad1d1b16ca88d7100703dc2544bcf9f19319f
ToppCell	BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell\|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)	TNIK ARHGAP15 GSPT1 STK4 BCL11B ARID5B	5.28e-05	198	148	6	8a7897d98f5296745d9005a7cd777f0a2f78000d
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T\|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)	TNIK GSPT1 BCL11B NSA2 HSPA8 DYRK2	5.28e-05	198	148	6	0b9d3518d60d877e1423517fab374381bf678a2b
ToppCell	Parenchymal-NucSeq\|Parenchymal / Cell types per location group and 10X technology with lineage, and cell group designations	DOCK4 ZBTB20 TTC28 GLIS3 KIAA1328 EXOC6B	5.28e-05	198	148	6	1996373bdccc55aac347d349bd22f6aad6d0c668
ToppCell	Sepsis-URO-Lymphocyte-T/NK-CD8+_T_naive\|URO / Disease, condition lineage and cell class	ACACB ARHGAP15 GLIS3 BCL11B CTH HSPA8	5.28e-05	198	148	6	c07426d4119b53e58eb5f448ae364f47cac1fc5c
ToppCell	severe-Lymphocytic-CD4_T_cells_1\|severe / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs	RPL26 BCL11B NSA2 HSPA8 RPL15 DYRK2	5.28e-05	198	148	6	2ae52051f7aeaaa4fc739914ac396ba49eaa525d
ToppCell	BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T\|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)	TNIK ARHGAP15 STK4 BCL11B ARID5B HSPA8	5.28e-05	198	148	6	33a3b279c9ff3b762e52d060dae062167ca2239b
ToppCell	MS-IIF-Lymphocyte-T/NK-CD4+_Tcm\|IIF / Disease, condition lineage and cell class	RPL26 ARHGAP15 BCL11B ARID5B HSPA8 RPL15	5.58e-05	200	148	6	f5c570a03eac54a81921630c79f5bccab05d3452
ToppCell	URO-Lymphocyte-T_NK-CD8_Naive\|URO / Disease, Lineage and Cell Type	ACACB ARHGAP15 GLIS3 BCL11B CTH	8.54e-05	134	148	5	142b7db0c2b686c8f2704ff7bcd9b44dfcb07403
Computational	Genes in the cancer module 227.	BLVRB UGT2B4 UGT2B7 UGT2B15	2.26e-06	15	71	4	MODULE_227
Computational	Steroid hormone and heme metabolism.	UGT2B4 UGT2B7 UGT2B10 UGT2B15	3.00e-06	16	71	4	MODULE_505
Drug	C1 11-32	UGT2A1 UGT2B4 UGT2B7 UGT2B10 UGT2B15 UGT2B17	1.01e-09	18	144	6	CID000443077
Drug	C11131	UGT2A1 UGT2B4 UGT2B7 UGT2B10 UGT2B15 UGT2B17	1.01e-09	18	144	6	CID000443076
Drug	T4-G	UGT2A1 UGT2B4 UGT2B7 UGT2B10 UGT2B15 UGT2B17	1.46e-09	19	144	6	CID000152424
Drug	estriol-16-glucuronide	UGT2A1 UGT2B4 UGT2B7 UGT2B10 UGT2B15 UGT2B17	2.89e-09	21	144	6	CID000122281
Drug	phenolphthalein	PROK2 GLG1 UGT2A1 UGT2B4 UGT2B7 UGT2B10 UGT2B15 UGT2B17	3.09e-09	58	144	8	CID000004764
Drug	estradiol-3-glucuronide	UGT2A1 UGT2B4 UGT2B7 UGT2B10 UGT2B15 UGT2B17	5.33e-09	23	144	6	CID000066651
Drug	L-idaro-1,4-lactone	UGT2A1 UGT2B4 UGT2B7 UGT2B10 UGT2B15 UGT2B17	1.94e-08	28	144	6	CID000078997
Drug	7-hydroxycoumarin glucuronide	UGT2A1 UGT2B4 UGT2B7 UGT2B10 UGT2B15 UGT2B17	2.43e-08	29	144	6	CID000125641
Drug	16-epiestriol	PSMD4 GLG1 UGT2A1 UGT2B4 UGT2B7 UGT2B10 UGT2B15 UGT2B17	3.07e-08	77	144	8	CID000003269
Drug	AC1Q6OQG	UGT2A1 UGT2B4 UGT2B7 UGT2B10 UGT2B15 UGT2B17	5.55e-08	33	144	6	CID000009686
Drug	BP-3,6-quinol	UGT2A1 UGT2B4 UGT2B7 UGT2B10 UGT2B15 UGT2B17	5.55e-08	33	144	6	CID000119292
Drug	AC1NOWCJ	UGT2A1 UGT2B4 UGT2B7 UGT2B10 UGT2B15 UGT2B17	8.04e-08	35	144	6	CID005120112
Drug	3-[(3S,5R,10S,13R,14S,17R)-3-[(2S,4R,5R,6S)-4,5-dihydroxy-6-methyloxan-2-yl]oxy-14-hydroxy-10,13-dimethyl-1,2,3,4,5,6,7,8,9,11,12,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]-2H-furan-5-one	UGT2A1 UGT2B4 UGT2B7 UGT2B10 UGT2B15 UGT2B17	8.04e-08	35	144	6	CID010436171
Drug	estrone-3-glucuronide	UGT2A1 UGT2B4 UGT2B7 UGT2B10 UGT2B15 UGT2B17	8.04e-08	35	144	6	CID000115255
Drug	l-borneol	UGT2A1 UGT2B4 UGT2B7 UGT2B10 UGT2B15 UGT2B17	1.14e-07	37	144	6	CID000010049
Drug	harmol	UGT2A1 UGT2B4 UGT2B7 UGT2B10 UGT2B15 UGT2B17	1.85e-07	40	144	6	CID000068094
Drug	testosterone glucuronide	UGT2A1 UGT2B4 UGT2B7 UGT2B10 UGT2B15 UGT2B17	2.16e-07	41	144	6	CID000108192
Drug	2-AF	UGT2A1 UGT2B4 UGT2B7 UGT2B10 UGT2B15 UGT2B17	2.16e-07	41	144	6	CID000005800
Drug	androsterone glucuronide	UGT2A1 UGT2B4 UGT2B7 UGT2B10 UGT2B15 UGT2B17	2.90e-07	43	144	6	CID000114833
Drug	7,8-benzoquinoline	UGT2A1 UGT2B4 UGT2B7 UGT2B10 UGT2B15 UGT2B17	2.90e-07	43	144	6	CID000009191
Drug	MS-222	UGT2A1 UGT2B4 UGT2B7 UGT2B10 UGT2B15 UGT2B17	3.34e-07	44	144	6	CID000011400
Drug	eugenol	TRPM7 UGT2A1 UGT2B4 UGT2B7 UGT2B10 UGT2B15 UGT2B17	4.02e-07	73	144	7	CID000003314
Drug	Hymecromone	UGT2A1 UGT2B4 UGT2B7 UGT2B15 UGT2B17	4.53e-07	25	144	5	ctd:D006923
Drug	salicylamide	UGT2A1 UGT2B4 UGT2B7 UGT2B10 UGT2B15 UGT2B17	5.68e-07	48	144	6	CID000005147
Drug	fibrates	CLCN1 UGT2A1 UGT2B4 UGT2B7 UGT2B10 UGT2B15 UGT2B17 HSPA8	8.57e-07	118	144	8	CID000002797
Drug	AC1NQGK1	UGT2A1 UGT2B4 UGT2B7 UGT2B10 UGT2B15 UGT2B17	9.24e-07	52	144	6	CID005195977
Drug	oxazepam	UGT2A1 UGT2B4 UGT2B7 UGT2B10 UGT2B15 UGT2B17	1.04e-06	53	144	6	CID000004616
Drug	menthol	TRPM7 UGT2A1 UGT2B4 UGT2B7 UGT2B10 UGT2B15 UGT2B17	1.34e-06	87	144	7	CID000001254
Drug	7-methoxycoumarin	UGT2A1 UGT2B4 UGT2B7 UGT2B10 UGT2B15 UGT2B17	1.60e-06	57	144	6	CID000010748
Drug	NNAL	UGT2B4 UGT2B7 UGT2B10 UGT2B15 UGT2B17	1.66e-06	32	144	5	CID000104856
Drug	4-aminobiphenyl	UGT2A1 UGT2B4 UGT2B7 UGT2B10 UGT2B15 UGT2B17 MOCS1	1.96e-06	92	144	7	CID000007102
Drug	urochloralic acid	UGT2A1 UGT2B4 UGT2B7 UGT2B10 UGT2B15 UGT2B17	1.97e-06	59	144	6	CID003036914
Drug	4-hydroxybiphenyl	UGT2A1 UGT2B4 UGT2B7 UGT2B10 UGT2B15 UGT2B17	1.97e-06	59	144	6	CID000007103
Drug	4-hydroxyestrone	UGT2A1 UGT2B4 UGT2B7 UGT2B10 UGT2B15 UGT2B17	1.97e-06	59	144	6	CID000018418
Drug	acetaminophen glucuronide	UGT2A1 UGT2B4 UGT2B7 UGT2B10 UGT2B15 UGT2B17	1.97e-06	59	144	6	CID000083944
Drug	SN-38G	UGT2A1 UGT2B4 UGT2B7 UGT2B10 UGT2B15 UGT2B17	1.97e-06	59	144	6	CID000443154
Drug	2-naphthol	ARHGAP4 UGT2A1 UGT2B4 UGT2B7 UGT2B10 UGT2B15 UGT2B17	2.10e-06	93	144	7	CID000008663
Drug	UDP-alpha-d-xylopyranose	UGT2A1 UGT2B4 UGT2B7 UGT2B10 UGT2B15 UGT2B17	2.18e-06	60	144	6	CID000001165
Drug	phenolphthalin	UGT2B4 UGT2B7 UGT2B15	2.45e-06	5	144	3	CID000066494
Drug	Amobarbital	UGT2B4 UGT2B7 UGT2B15	2.45e-06	5	144	3	ctd:D000654
Drug	3-OHBaP	UGT2A1 UGT2B4 UGT2B7 UGT2B10 UGT2B15 UGT2B17	2.91e-06	63	144	6	CID000025890
Drug	Dinoprost trometamol [38362-01-5]; Up 200; 8.4uM; PC3; HT_HG-U133A	EPHB2 CDK9 ABCA2 ZNF276 BCL11B CCT6B ULK2 MOCS1 ZNF222	4.15e-06	194	144	9	6308_UP
Drug	Meldola	UGT2A1 UGT2B4 UGT2B7 UGT2B10 UGT2B15 UGT2B17	4.57e-06	68	144	6	CID000081507
Drug	4-(methylnitrosamino)-1-(3-pyridyl)-1-butan-1-ol	UGT2B7 UGT2B10 UGT2B17	4.89e-06	6	144	3	ctd:C475721
Drug	4-((methylnitrosoamino)-1-(3-pyridyl)but-1-yl)beta-omega-glucosiduronic acid	UGT2B7 UGT2B10 UGT2B17	4.89e-06	6	144	3	ctd:C099564
Drug	2-hydroxyestriol	UGT2B4 UGT2B7 UGT2B10	4.89e-06	6	144	3	CID000014688
Drug	lorcaserin	UGT2B7 UGT2B15 UGT2B17	4.89e-06	6	144	3	ctd:C506658
Drug	Metaproterenol sulfate, orciprenaline sulfate [5874-97-5]; Up 200; 7.6uM; MCF7; HT_HG-U133A	EPHB2 GAD1 CAMK1D ACACB ARHGEF12 ADAM22 USP7 CTH MOCS1	4.91e-06	198	144	9	2845_UP
Drug	methoxyresorufin	UGT2A1 UGT2B4 UGT2B7 UGT2B10 UGT2B15 UGT2B17	4.98e-06	69	144	6	CID000119220
Drug	2-acetylaminofluorene	PSMD4 LATS1 UGT2A1 UGT2B4 UGT2B7 UGT2B10 UGT2B15 UGT2B17 HSPA8 MOCS1	6.81e-06	262	144	10	CID000005897
Drug	N'-nitrosoanatabine	UGT2B4 UGT2B7 UGT2B10 UGT2B17	6.87e-06	20	144	4	CID000051291
Drug	AC1L1OBF	UGT2B4 UGT2B7 UGT2B15 UGT2B17	6.87e-06	20	144	4	CID000032736
Drug	2,2,2-trichloroethanol	UGT2A1 UGT2B4 UGT2B7 UGT2B10 UGT2B15 UGT2B17	6.93e-06	73	144	6	CID000008259
Drug	7-hydroxycoumarin	UGT2A1 UGT2B4 UGT2B7 UGT2B10 UGT2B15 UGT2B17	8.11e-06	75	144	6	CID005281426
Drug	ranirestat	UGT2B4 UGT2B7 UGT2B15	8.51e-06	7	144	3	ctd:C115070
Drug	benzyloxyresorufin	UGT2A1 UGT2B4 UGT2B7 UGT2B10 UGT2B15 UGT2B17	1.02e-05	78	144	6	CID000114982
Drug	AC1N8H7N	UGT2A1 UGT2B4 UGT2B7 UGT2B10 UGT2B15 UGT2B17	1.02e-05	78	144	6	CID004318740
Drug	N'-nitrosoanabasine	UGT2B4 UGT2B7 UGT2B10 UGT2B17	1.03e-05	22	144	4	CID000014335
Drug	acridine	UGT2A1 UGT2B4 UGT2B7 UGT2B10 UGT2B15 UGT2B17	1.27e-05	81	144	6	CID000009215
Drug	5 alpha-androstane	UGT2A1 UGT2B4 UGT2B7 UGT2B10 UGT2B15 UGT2B17	1.56e-05	84	144	6	CID000094144
Drug	scopoletin	UGT2A1 UGT2B4 UGT2B7 UGT2B15 UGT2B17	1.59e-05	50	144	5	CID005280460
Drug	7-ethoxycoumarin	UGT2A1 UGT2B4 UGT2B7 UGT2B10 UGT2B15 UGT2B17	1.79e-05	86	144	6	CID000035703
Drug	AC1L1FK5	PSMD4 UGT2A1 UGT2B4 UGT2B7 UGT2B10 UGT2B15 UGT2B17	1.84e-05	129	144	7	CID000003272
Drug	pentoxyresorufin	UGT2A1 UGT2B4 UGT2B7 UGT2B10 UGT2B15 UGT2B17	1.91e-05	87	144	6	CID000107683
Drug	Bortezomib	EPHB2 RPL26 ABCA2 HDAC6 ERN1 PRDM2 ZFX GSPT1 BLVRB STK4 CTH CTNNB1 KAT6B MAP2K1 HSPA6 HSPA7 FAM118B	2.32e-05	838	144	17	ctd:D000069286
Drug	licochalcone A	UGT2B4 UGT2B7 UGT2B15 UGT2B17	2.41e-05	27	144	4	ctd:C070840
Drug	p-nitroanisole	UGT2A1 UGT2B4 UGT2B7 UGT2B10 UGT2B15 UGT2B17	2.63e-05	92	144	6	CID000007485
Drug	DNCB	UGT2A1 UGT2B4 UGT2B7 UGT2B10 UGT2B15 UGT2B17 CTH HSPA6	2.80e-05	189	144	8	CID000000006
Drug	ethoxyresorufin	UGT2A1 UGT2B4 UGT2B7 UGT2B10 UGT2B15 UGT2B17	3.16e-05	95	144	6	CID000003294
Drug	DCNB	UGT2A1 UGT2B4 UGT2B7 UGT2B10 UGT2B15 UGT2B17	3.16e-05	95	144	6	CID000007443
Drug	aniline	UGT2A1 UGT2B4 UGT2B7 UGT2B10 UGT2B15 UGT2B17 MAP2K1	3.41e-05	142	144	7	CID000006115
Drug	DB04103	UGT2A1 UGT2B4 UGT2B7 UGT2B10 UGT2B15 UGT2B17	3.55e-05	97	144	6	CID004469987
Drug	Serotonin hydrochloride [153-98-0]; Up 200; 18.8uM; MCF7; HT_HG-U133A	EPHB2 CAMK1D ACACB ARHGEF12 ADAM22 ARHGAP4 LATS1 MTRF1L	3.76e-05	197	144	8	3311_UP
Drug	1-naphthol	UGT2A1 UGT2B4 UGT2B7 UGT2B10 UGT2B15 UGT2B17	3.76e-05	98	144	6	CID000007005
Drug	2 E1	ARHGAP4 UGT2A1 UGT2B4 UGT2B7 UGT2B10 UGT2B15 UGT2B17	3.90e-05	145	144	7	CID006102788
Drug	1,4-benzodiazepine	UGT2B4 UGT2B7 UGT2B15	3.94e-05	11	144	3	CID000148431
Drug	3-hydroxyandrostan-17-one	UGT2A1 UGT2B4 UGT2B7 UGT2B10 UGT2B15 UGT2B17	4.71e-05	102	144	6	CID000000225
Drug	anethole trithione	UGT2B4 UGT2B7 UGT2B10 UGT2B15 UGT2B17	4.94e-05	63	144	5	CID000002194
Drug	R(-)-Denopamine	UGT2B4 UGT2B7 UGT2B15 UGT2B17	5.44e-05	33	144	4	CID000003818
Drug	chrysin	UGT2A1 UGT2B4 UGT2B7 UGT2B10 UGT2B15 UGT2B17	5.85e-05	106	144	6	CID005281607
Drug	AC1L45AJ	UGT2B4 UGT2B7 UGT2B17 CXCR1	6.14e-05	34	144	4	CID000200882
Drug	fluconazole	UGT2A1 UGT2B4 UGT2B7 UGT2B10 UGT2B15 UGT2B17	6.17e-05	107	144	6	CID000003365
Drug	Aroclor 1254	SLC8A3 UGT2A1 UGT2B4 UGT2B7 UGT2B10 UGT2B15 UGT2B17 HSPA8	6.52e-05	213	144	8	CID000040470
Drug	disulfiram	GAD1 UGT2A1 UGT2B4 UGT2B7 UGT2B10 UGT2B15 UGT2B17	6.73e-05	158	144	7	CID000003117
Drug	cotinine-N-glucuronide	UGT2B7 UGT2B10 UGT2B15	6.76e-05	13	144	3	CID000000411
Drug	2-naphthylamine	UGT2A1 UGT2B4 UGT2B7 UGT2B10 UGT2B15 UGT2B17	7.20e-05	110	144	6	CID000007057
Drug	taurin	UGT2B4 CTH CTNNB1	8.57e-05	14	144	3	CID000211707
Drug	al-Badry	POLR2B UGT2A1 UGT2B4 UGT2B7 UGT2B10 UGT2B15 UGT2B17	8.84e-05	165	144	7	CID000004545
Drug	ethoxyquin	UGT2A1 UGT2B4 UGT2B7 UGT2B10 UGT2B15 UGT2B17	9.66e-05	116	144	6	CID000003293
Drug	lithocholic acid	UGT2A1 UGT2B4 UGT2B7 UGT2B10 UGT2B15 UGT2B17	9.66e-05	116	144	6	CID000009903
Drug	estrone-d4	TRPM7 UGT2A1 UGT2B4 UGT2B7 UGT2B10 UGT2B15 UGT2B17	9.89e-05	168	144	7	CID000000698
Drug	AC1Q7AUJ	UGT2A1 UGT2B4 UGT2B7 UGT2B10 UGT2B15 UGT2B17	1.01e-04	117	144	6	CID000003303
Drug	alpha-naphthoflavone	UGT2A1 UGT2B4 UGT2B7 UGT2B10 UGT2B15 UGT2B17	1.06e-04	118	144	6	CID000011790
Drug	flurbiprofen	ERN1 TRPM7 BLVRB UGT2B4 UGT2B7 UGT2B17 DLST	1.10e-04	171	144	7	CID000003394
Drug	benzphetamine	UGT2A1 UGT2B4 UGT2B7 UGT2B10 UGT2B15 UGT2B17	1.11e-04	119	144	6	CID000002341
Drug	oxazepam glucuronide	UGT2B7 UGT2B15	1.19e-04	3	144	2	ctd:C026256
Drug	5 alpha-dihydroaldosterone	UGT2B4 UGT2B7	1.19e-04	3	144	2	CID003036614
Drug	UDP - Na	RRM2 UGT2A1 UGT2B4 UGT2B7 UGT2B10 UGT2B15 UGT2B17 MOCOS	1.29e-04	235	144	8	CID000001158
Drug	PTBP	UGT2B4 UGT2B7 UGT2B10 UGT2B15	1.43e-04	42	144	4	CID000007393
Drug	hexobarbital	UGT2A1 UGT2B4 UGT2B7 UGT2B10 UGT2B15 UGT2B17	1.59e-04	127	144	6	CID000003608
Disease	deoxycholic acid glucuronide measurement	UGT2B7 UGT2B10 UGT2B15 UGT2B17	3.07e-08	8	137	4	EFO_0800575
Disease	plasma clozapine-to-N-desmethylclozapine ratio measurement	UGT2B4 UGT2B7 UGT2B10 UGT2B15	5.50e-08	9	137	4	EFO_0600040
Disease	X-19141 measurement	UGT2B4 UGT2B7 UGT2B15 UGT2B17	3.08e-07	13	137	4	EFO_0800799
Disease	X-24947 measurement	UGT2B4 UGT2B7 UGT2B15 UGT2B17	3.05e-06	22	137	4	EFO_0800910
Disease	vanillylmandelate (VMA) measurement	UGT2B4 UGT2B10 UGT2B15	3.38e-06	7	137	3	EFO_0800119
Disease	X-12007 measurement	UGT2B10 UGT2B15	2.14e-05	2	137	2	EFO_0021276
Disease	Abnormality of the sense of smell, COVID-19 symptoms measurement, ageusia	UGT2A2 UGT2A1	2.14e-05	2	137	2	EFO_0600019, EFO_1001758, HP_0004408
Disease	serum clozapine-to-N-desmethylclozapine ratio measurement	UGT2B10 UGT2B15	6.40e-05	3	137	2	EFO_0600042
Disease	cholic acid glucuronide measurement	UGT2B15 UGT2B17	6.40e-05	3	137	2	EFO_0800574
Disease	testosterone measurement	DOCK4 ZBTB20 TTC28 UGT2A2 GLIS3 DGKB BCL11B UGT2A1 ARID5B USP7 UGT2B4 UGT2B7 UGT2B10 UGT2B15 UGT2B17 VARS1 ZNF654	9.06e-05	1275	137	17	EFO_0004908
Disease	androsterone glucuronide measurement	UGT2B4 UGT2B15 UGT2B17	1.05e-04	20	137	3	EFO_0800317
Disease	X-25937 measurement	UGT2B15 UGT2B17	1.28e-04	4	137	2	EFO_0800937
Disease	X-16576 measurement	UGT2B10 UGT2B15	1.28e-04	4	137	2	EFO_0800760
Disease	carcinoma (implicated_via_orthology)	STK4 LATS1 CTNNB1 FGR	2.28e-04	64	137	4	DOID:305 (implicated_via_orthology)
Disease	cortolone glucuronide (1) measurement	UGT2B10 UGT2B15	3.17e-04	6	137	2	EFO_0800552
Disease	cotinine measurement, trans-3-hydroxycotinine measurement	UGT2B10 UGT2B15	3.17e-04	6	137	2	EFO_0007813, EFO_0010707
Disease	unipolar depression, bipolar disorder, seasonality measurement	ZBTB20 DGKB C6orf118	3.63e-04	30	137	3	EFO_0003761, EFO_0006876, MONDO_0004985
Disease	X-24574 measurement	UGT2B15 UGT2B17	4.43e-04	7	137	2	EFO_0800897
Disease	X-24418 measurement	UGT2B4 UGT2B15	4.43e-04	7	137	2	EFO_0800879
Disease	malignant epithelial tumor of ovary	UGT2A2 UGT2A1 UGT2B4	5.75e-04	35	137	3	MONDO_0018364
Disease	serum N-desmethylclozapine measurement	UGT2B10 UGT2B15	5.88e-04	8	137	2	EFO_0600043
Disease	blindness (implicated_via_orthology)	RPL26 RPL26L1	5.88e-04	8	137	2	DOID:1432 (implicated_via_orthology)
Disease	X-12844 measurement	UGT2B4 UGT2B15	7.54e-04	9	137	2	EFO_0021339
Disease	4-androsten-3alpha,17alpha-diol monosulfate (3) measurement	UGT2B15 UGT2B17	9.40e-04	10	137	2	EFO_0022090
Disease	DNA repair protein RAD51 homolog 4 measurement	UGT2B15 UGT2B17	1.15e-03	11	137	2	EFO_0801531
Disease	plasma N-desmethylclozapine measurement	UGT2B10 UGT2B15	1.15e-03	11	137	2	EFO_0600039
Disease	Gastric Adenocarcinoma	ERN1 TRPM7 CTNNB1	1.20e-03	45	137	3	C0278701
Disease	diabetic maculopathy	C6orf118 USP7	1.37e-03	12	137	2	EFO_0010133
Disease	5alpha-androstan-3beta,17beta-diol monosulfate (2) measurement	UGT2B15 UGT2B17	1.37e-03	12	137	2	EFO_0800291
Disease	androstenediol (3alpha, 17alpha) monosulfate (3) measurement	UGT2B15 UGT2B17	1.61e-03	13	137	2	EFO_0800293
Disease	cancer (implicated_via_orthology)	TRIP12 STK4 LATS1 CTNNB1 FGR MAP2K1	1.62e-03	268	137	6	DOID:162 (implicated_via_orthology)
Disease	corneal topography	ZNF469 SLC8A3 BCL11B ARID5B	1.70e-03	109	137	4	EFO_0004345
Disease	5alpha-androstan-3alpha,17alpha-diol monosulfate measurement	UGT2B15 UGT2B17	1.88e-03	14	137	2	EFO_0800283
Disease	Aase Smith syndrome 2	RPL26 RPL15	2.16e-03	15	137	2	C2931850
Disease	lymphocyte measurement	CTU2 ERN1 TTC28 ARID5B	2.20e-03	117	137	4	EFO_0803546
Disease	lung disease severity measurement	CAMK1D DGKB BCL11B GLIS1	2.27e-03	118	137	4	EFO_0007744
Disease	2-hydroxyglutarate measurement	DGLUCY CTH	2.46e-03	16	137	2	EFO_0021506
Disease	low affinity immunoglobulin gamma Fc region receptor II-a measurement	HSPA6 HSPA7	2.78e-03	17	137	2	EFO_0021969
Disease	Adenocarcinoma of lung (disorder)	ERN1 RRM2 LATS1 CTNNB1 MAP2K1	2.80e-03	206	137	5	C0152013
Disease	5alpha-androstan-3alpha,17beta-diol monosulfate (1) measurement	UGT2B15 UGT2B17	3.12e-03	18	137	2	EFO_0800288
Disease	cotinine glucuronidation measurement	UGT2B10 UGT2B15	3.47e-03	19	137	2	EFO_0006508
Disease	Diamond-Blackfan anemia	RPL26 RPL15	3.47e-03	19	137	2	cv:C1260899
Disease	etiocholanolone glucuronide measurement	UGT2B15 UGT2B17	3.47e-03	19	137	2	EFO_0800362
Disease	anti-Mullerian hormone measurement	TTC28 RRM2	3.85e-03	20	137	2	EFO_0004769
Disease	Prostate cancer, familial	EPHB2 TTC28 MAP2K1	4.10e-03	69	137	3	C2931456
Disease	intrinsic cardiomyopathy (implicated_via_orthology)	CCT6A CCT6B	4.24e-03	21	137	2	DOID:0060036 (implicated_via_orthology)
Disease	haptoglobin measurement	DHX38 HYDIN	4.24e-03	21	137	2	EFO_0004640

Protein segments in the cluster

Peptide	Gene	Start	Entry
VLDHGARHPDMKKRV	CCT6A	211	P40227
KQHMSSRRHKDRLAG	ZNF385C	306	Q66K41
MAAHRKHVFVEKVLQ	ERICH1	1	Q86X53
DFRSHDKIPHIRMNK	CRYBG3	571	Q68DQ2
RFGGQKHVVHMRVKK	ADAM21	66	Q9UKJ8
DHIRMHKVLRESGLK	BLVRB	131	P30043
VNDHLMFKKHRLSVV	ADAM22	246	Q9P0K1
AYVEMKRKKRVHFHG	AFG1L	151	Q8WV93
KRKKRVHFHGFMLDV	AFG1L	156	Q8WV93
FMLDVHKRIHRLKQS	AFG1L	166	Q8WV93
NRGLKTLHVRMEKHF	CTH	256	P32929
EKKHKRFQELDRFMH	ANKIB1	586	Q9P2G1
GRAMELQKARHPKHL	ARHGEF12	616	Q9NZN5
GLTYLREKHKIMHRD	MAP2K1	176	Q02750
IRPMGLRFKKAHVTH	NSA2	171	O95478
HHTFKKMLPRDERRF	RCN1	161	Q15293
QRKHMLQEKLHLRFC	PTPN23	1431	Q9H3S7
RSFKGHVRKMLRHAE	PUM3	236	Q15397
LVSEGNKMHFRLHRK	PCDHB1	66	Q9Y5F3
NKMHFRLHRKTGDLF	PCDHB1	71	Q9Y5F3
TLQHLHMIDKRDGRF	KAT6B	941	Q8WYB5
MSGLHLVKRGREHKK	ACACB	221	O00763
LAVHMFIDRHKQLRA	CACNG2	196	Q9Y698
HQLSKKEASRHAIMR	CTNNB1	176	P35222
RGDHVKHYKIRKLDM	FGR	191	P09769
VESVHKMGFIHRDIK	LATS1	816	O95835
KDLRVHLKMVDSFHR	PPFIA4	981	O75335
VRFIHFLHKAKNRME	NCCRP1	241	Q6ZVX7
LMSRKHRHKLNGIER	GAD1	381	Q99259
ALQKKREIHMAKAHR	MBD3L5	26	A6NJ08
RGAHRIHVEMKFSVR	EPHB2	81	P29323
FQHMHIKVGDRAELR	HTD2	31	P86397
AQQHFHVKVRAMDKG	FAT2	2341	Q9NYQ8
KMRGGSILSHIHKRR	MKNK2	161	Q9HBH9
ALQKKREIHMAKAHR	MBD3L2B	26	A0A1B0GVZ6
RHLGISNEMVRKHFQ	MOCOS	431	Q96EN8
FKHLGRLLMVHGRNS	ATP9A	821	O75110
HGRFMEKLETRIRNH	EXOC6B	46	Q9Y2D4
DLRKGKDQMHSHRKR	DPRX	6	A6NFQ7
REHAMLAKTAGVKHL	GSPT1	201	P15170
RKERKTVGFHSHMKD	KIAA1328	441	Q86T90
NHFMEEFRRKHGKDL	HSPA7	241	P48741
ALQKKREIHMAKAHR	MBD3L3	26	A6NE82
VRRKGFHKVMEGIHK	MOCS1	191	Q9NZB8
EMRARHKEAFLKKHN	DLST	261	P36957
FHREHRARAEKMKHL	OOEP	116	A6NGQ2
KRKKEVPFFGRRMHH	PROK2	91	Q9HC23
IAHRFHVMREKHPEK	DGKG	591	P49619
HRKGRTLHCLMKVVR	GLG1	456	Q92896
FHSQKVGRMRGIIHL	HYDIN	3576	Q4G0P3
MGHKFLKHIERTRQL	GTPBP10	216	A4D1E9
RHMKTHGQIGKEVYR	BCL11B	841	Q9C0K0
VGHLTHDRMKDVKRH	DOCK4	131	Q8N1I0
HDRMKDVKRHITARL	DOCK4	136	Q8N1I0
SVRDLLRAMRNKKHH	ERN1	896	O75460
DILIHGMKARNRSIH	DIS3L	276	Q8TF46
RYKLLIHMRVHSGEK	GLIS3	396	Q8NEA6
QRKHLAAHGLTMLFE	INTS14	26	Q96SY0
HRKAEEHFQKGLRMK	IFIT1B	356	Q5T764
LRTLFKAHMGQKHRA	CXCR1	226	P25024
AMHGLVSKEFLARHR	CXCR1	321	P25024
KVARMKEALAHFTIH	C6orf118	101	Q5T5N4
AHRFHIMREKHPEKF	DGKB	596	Q9Y6T7
RNFPEAMLKERHHTK	ABCA2	2301	Q9BZC7
KRKDFGIMFLHHLVS	CERS6	201	Q6ZMG9
VKHKSDLEHFMLVRR	FAM118B	266	Q9BPY3
HVRRNALALHAQMKK	KANSL2	91	Q9H9L4
NHFMEEFRRKHGKDL	HSPA6	241	P17066
VMKKQVIRRCEHGHK	CCDC168	5831	Q8NDH2
GHLRATEKMKTRELH	HDAC6	546	Q9UBN7
GMGKVKEAVRRHIRH	DGLUCY	486	Q7Z3D6
RYKLLIHMRVHSGEK	GLIS1	246	Q8NBF1
HRNKILHRDMKAANV	CDK9	141	P50750
HVRGFQAMKKIHLAQ	CEP295	241	Q9C0D2
RMDRKHGKYILNVEH	DYNAP	26	Q8N1N2
ALKHRQGKNHKMRII	PSMD4	96	P55036
QHVALKMVRNEKRFH	DYRK2	246	Q92630
KVAHLKEHRRVFQAM	NOC4L	241	Q9BVI4
VHKFRAMLGKNRLIF	CTU2	56	Q2VPK5
EKMFLHVKGEIHLGR	C9	291	P02748
HVKGEIHLGRFVMRN	C9	296	P02748
ALQKKREIHMAKAHR	MBD3L4	26	A6NDZ8
ERKFTTKQGLERHMH	PRDM2	366	Q13029
RMVNHFIAEFKRKHK	HSPA8	236	P11142
ALQKKREIHMAKAHR	MBD3L2	26	Q8NHZ7
KRHFNAPSHVRRKIM	RPL26L1	16	Q9UNX3
MHGALGRLLDKHFKR	OR1D2	296	P34982
LHAIVRDAHGRKMSK	VARS1	851	P26640
VLDHGARHPDMKKRV	CCT6B	211	Q92526
CGKRFMRSDHLAKHV	SP5	361	Q6BEB4
RHMKFEGGVHRVQRV	MTRF1L	191	Q9UGC7
GRMHAAVHKDLVFIV	KBTBD4	421	Q9NVX7
HRRFAQKVNMLKHCK	PRDM15	1146	P57071
HVVFLIVQKAHRKMR	GUCY1B2	101	O75343
QKPEHRKSLMFRLHH	ARHGAP15	226	Q53QZ3
FQKILGMHRRHTVDE	RAPGEF5	196	Q92565
LKHMVDDKIHSRARG	POLR2B	1051	P30876
NATAVVRHMRKLHLG	CAMK1D	311	Q8IU85
GGRLVEKRQAKFMEH	ARHGAP4	221	P98171
VILRKHSDHRMREKA	ABHD10	271	Q9NUJ1
RKMIKHALDFIHHFN	ASPA	196	P45381
GKPHHVRLENFRKME	ARID5B	976	Q14865
VYLHRQVMLGVRKHK	CLCN1	366	P35523
KDITSLFRHLHMRQK	PIK3R4	736	Q99570
LFRHLHMRQKKRNGS	PIK3R4	741	Q99570
RDHGDMTNRKFRHDK	PRPF8	71	Q6P2Q9
GKAFMHKAQLVVHQR	ZNF684	221	Q5T5D7
HLDGVFMHKRAQRLK	TNIK	1311	Q9UKE5
FNRKDKLKRHMLIHE	ZNF341	631	Q9BYN7
FEARDLRQHMNKHLG	ZBTB11	776	O95625
FRKHGLAHDEMKSPR	THRAP3	686	Q9Y2W1
GKALSHLKSFQRHMI	ZNF441	481	Q8N8Z8
MFKHLVHKPSEERVR	RRM2	276	P31350
FVMRHKGAKHLRVAA	UGT2B4	466	P06133
HKHREMRGLTSAGRK	RPL15	156	P61313
KRHFNAPSHIRRKIM	RPL26	16	P61254
KGKEVIIHRLLSMFH	SELENON	246	Q9NZV5
LKIQKERDFHRMHHK	SPAG16	186	Q8N0X2
GSIKERYDHRLMLKH	TTBK2	236	Q6IQ55
SLKMHRLKHEGKRCF	ZBTB44	441	Q8NCP5
KQRKHLLVHQMRHSG	ZNF276	506	Q8N554
FRNRGLMQKHLKNHV	ZNF654	581	Q8IZM8
HFIHAKAMRKVREVR	DHX38	1031	Q92620
GKAFRLHMQLIRHQK	ZNF780A	591	O75290
GKAFRLHMHLIRHQK	ZNF780B	591	Q9Y6R6
KSSLNVHMRLHRGEK	ZBTB20	646	Q9HC78
KKEQFDRHMNKHLRG	ZNF469	3401	Q96JG9
AAAMRILHSKGIIHR	ULK2	116	Q8IYT8
NHRHQLVLAMKLKDR	TTC28	296	Q96AY4
AKEMHLKGRRHRLQY	ZFR	596	Q96KR1
HERLHMKRRSKQALN	ZNF496	571	Q96IT1
MFKSKLVRHQRTHTG	ZNF416	476	Q9BWM5
GFRHPSELKKHMRIH	ZFX	556	P17010
RLHLSKAKMAHRREI	TRIM49D1	211	C9J1S8
VMRHKGAKHLRVAAH	UGT2B10	466	P36537
LHVHQRVHVGEKLFM	ZNF155	191	Q12901
HFMRKIHRDIKAGNI	STK4	141	Q13043
FNMQRKLVKHRIRHT	ZBTB49	516	Q6ZSB9
AVLRRHKKMHCKAGD	ZBTB49	576	Q6ZSB9
SKFQERHMKREHPAD	ZNF576	46	Q9H609
RHMKREHPADFVAQK	ZNF576	51	Q9H609
RLHLSKAKMAHRREI	TRIM49B	211	A6NDI0
EFVMRHKGAKHLRVA	UGT2B15	466	P54855
FVMRHKGAKHLRVAA	UGT2B7	466	P16662
FRREGVMHQVKHLAE	TRIP12	921	Q14669
MRHKGAKHLRVAAHD	UGT2A1	466	P0DTE4
IHQGEHFREVMKRIQ	USP7	1011	Q93009
KSHLMRHQRIHTGDK	ZNF605	601	Q86T29
GNRADKKEKMRHNHF	TRPM7	566	Q96QT4
EFVMRHKGAKHLRVA	UGT2B17	466	O75795
VIRMSHKKFHADAIL	KIAA0586	1281	Q9BVV6
IEFVMRHKGAKHLRV	UGT2A2	471	P0DTE5
GRGFIDRLDLHKHQM	ZNF222	291	Q9UK12
IKSRNAHMKRHRLQD	ZNF541	1301	Q9H0D2
LIIHQRMHSGEKRFI	ZNF606	751	Q8WXB4
KSRGFLKRHMKNHPE	ZFY	431	P08048
KGFRHPSELRKHMRI	ZFY	551	P08048
MHKKYRTDKHRGIII	SLC8A3	261	P57103